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...resistant bacteria can be transmitted from food-producing animals such as cattle, 
pigs and poultry, and the environment to humans, via the food chain.
Background
Antimicrobial resistance (AMR) associated with the 
food chain is currently a subject of major interest 
to many food chain stakeholders. In response 
safefood commissioned this report to update our 
knowledge of this area and to raise awareness of 
the issue. Its primary focus is on the food chain 
where it impacts consumer health. This review will 
inform and underpin any future action to be taken 
by safefood with regard to AMR.
What is antimicrobial resistance?
Antibiotics are important drugs used in the 
treatment of bacterial infections in both humans 
and animals. Emerging antibiotic resistance 
among certain bacteria is now frequently 
observed, thereby posing a serious threat to 
public health. Once these micro-organisms 
become resistant to one or more antibiotics, they 
do not respond to therapy. 
Some bacteria are naturally resistant, whilst 
others become resistant following selection after 
prolonged antibiotic use. Reservoirs of resistant 
bacteria may develop in the gastrointestinal (GI) 
tracts of food-producing animals following mis-use 
of these valuable therapeutic drugs. These resistant 
bacteria can be transmitted from food-producing 
animals such as cattle, pigs and poultry, and the 
environment to humans, via the food chain.
In this report, emphasis has been placed primarily 
on those bacteria of animal origin that infect 
humans via the food chain. Specifically this 
report reviews the scientific data available in 
relation to Salmonella	spp., verocytotoxigenic 
Escherichia	coli (VTEC), Campylobacter spp., all of 
which are important zoonotic bacteria. The report 
summarises information on other AMR bacteria 
such as methicillin-resistant Staphylococcus	
aureus (MRSA) and Clostridium	difficile that may 
have a food-borne role that has yet to be defined. 
Importantly, the document comments on 
commensal bacteria, which inhabit the GI tracts 
of animals and humans, these have hitherto 
been an unrecognised reservoir of resistance. 
Consideration is also given to the role of AMR 
in probiotic bacteria and genetically modified 
organisms (GMO). 
Executive Summary
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What causes bacteria to develop AMR and why 
is this important for food safety?
It is likely that the emergence of AMR in bacteria 
involves a complex series of events in humans, 
animals and the environment, occurring over 
an extended period. In the past AMR has been 
recognised in clinical and veterinary settings alone, 
and would never have been linked with the food 
chain. We derive much of our food from farmed 
animals, a feature that links human and animals 
alike. The food chain and the broader environment 
provide a convenient route, by which humans can 
become infected with AMR bacteria.
Emerging AMR: the potential exposure routes 
(1) Food-producing animals & the environment
AMR arises following the mis-use of antibiotics. 
Humans are exposed to or acquire AMR bacteria 
through selection pressure associated with 
prolonged use of these important drugs. 
Furthermore, humans may also be exposed 
through direct contact with animals and humans 
that may be colonised/infected with AMR 
bacteria. A lesser recognised route however, is 
the food chain which may contain AMR bacteria 
derived from food-producing animals or from 
cross-contamination during food processing.
In the environment, AMR bacteria can enter the 
food chain through the contamination of ground 
and surface water, or from the spraying of food 
crops with contaminated water containing AMR 
bacteria derived from human and animal waste. 
Where these crops are not processed further after 
harvest, this food source may pose an increased 
risk to public health.
(2) Food processing technologies
Food processing technologies are designed 
to reduce the risk of transmission of hazards 
including bacteria through the food chain. As 
bacteria become resistant, following the stress 
imposed through antibiotic selection, they may 
evolve and undergo genetic changes which make 
these organisms more difficult to eliminate. 
This may in turn increase the likelyhood of 
transmission through the food chain.
(3)  Use of sanitizing agents & biocides in food 
production
Sanitizers are used in the food industry to 
eliminate contaminating bacteria that may occur 
on food preparation surfaces or equipment in 
direct contact with food. Although sanitizers, 
biocides and antibiotics kill bacteria, there is 
increasing concern that resistance to these 
cleaning agents may directly or indirectly be 
linked to AMR. Concerns have been expressed 
in regard to the application of sanitizers and 
biocides in food processing and in domestic 
food preparation environments where they may 
promote the development and dissemination of 
AMR via the human food chain. Currently there is 
a need to develop a better understanding of this 
relationship (if any).
Human Health Impact
There are a range of human health consequences 
from AMR including protracted illness and 
even death. Vulnerable patients with impaired 
immunity are at greatest risk.
15
...the primary focus of this report is on food and food processing technology with 
particular impact on the consumer-health aspects. 
Strategies to reduce the emergence of  
AMR bacteria
On the island of Ireland there are two AMR 
strategies currently active, the Strategy for 
the control of Antimicrobial Resistance in the 
Republic of Ireland (SARI) and the Anti Microbial 
Resistance Action Plan (AMRAP) in Northern 
Ireland. Both SARI and AMRAP recommended the 
development of guidance protocols in relation to 
the appropriate use of antimicrobials (in humans), 
as well as strategies to monitor the supply and 
use of antimicrobials in our hospitals and the 
community. Education awareness programmes 
have been developed which are focussed on 
medical professionals, veterinary practitioners 
and the general public. These aim to create a 
better understanding of AMR and how it links to 
our broader society. Managing and controlling 
any future emergence of AMR micro-organisms 
will require a multi-disciplinary approach with 
imputs from all health care professionals and 
stakeholders in the food industry.
Recommendations
Based on the current safefood report the 
following recommendations were offered in 
support of the surveillance infrastructure and 
research requirements:
Surveillance:
• Intensify AMR surveillance in the animal 
population, across the food chain, and in the 
human population
• Integrate the all-island AMR Monitoring 
Programme (including prescribing, dispensing 
and consumption patterns in human and 
animal populations)
• Promote the prudent use of antimicrobial 
agents in animal and human medicine
• Establish a forum on AMR and food safety, 
including all stakeholders to insure delivery of 
the surveillance strategy.
Research:
• Improve our understanding of the impacts 
of AMR on current and alternative food 
processing technologies
• Food attribution studies should be undertaken 
to determine the fraction of food animal-
associated AMR infections on the island of 
Ireland and to assist with the identification 
and prioritisation of hazards posed.
Background and terms of reference of  
the report
Background:
There is already considerable activity and 
information on antimicrobial resistance (AMR) 
at the beginning and end of the human food 
chain i.e. veterinary and clinical. However, the 
primary focus of this report is on food and food 
processing technology with particular impact 
on the consumer-health aspects. This theme is 
appropriate to the remit of safefood. This area is 
under explored, although there is some current 
scientific literature on the relationship between 
AMR, modern food production and consumer/
food interaction. This review will inform and 
underpin any action to be untaken by safefood 
on AMR and food safety.
Terms of reference of the report:
• The prevalence of AMR bacteria (pathogens and 
commensals) in the food chain
• The impact of food processing stresses on the 
survival and evolution of AMR bacteria within 
food; and the transfer of AMR among bacteria 
within the food matrix
• The impact of currently used antimicrobials 
including disinfectants, sanitizers, surfactants 
and related decontamination treatments
• The human health impact of antimicrobial use 
in food animals
 Executive Summary
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...widespread use of antibiotics led to the emergence of antibiotic resistance in 
many important pathogens...
1
What are antibiotics? 
Antibiotics are low molecular weight microbial 
metabolites that can kill or inhibit the growth of 
sensitive bacteria. The term ‘antibiotic’ refers to 
drugs used to treat infectious diseases in animals, 
humans and plants and these substances may be 
naturally occurring, semi-synthetic or synthetic. 
Most of the drugs in use today were discovered 
between the years 1940 and 1970. Chemical 
modification of the structure of antibiotics leads to 
the development of new compounds with an altered 
spectrum of activity. The therapeutic benefit of 
antibiotics depends on their selective toxicity.
Widespread use of these drugs led to the 
emergence of antibiotic resistance in many 
important pathogens (Levy, 2002). This resistance 
contributes to higher rates of morbidity and, 
in the case of severe bacterial infections, 
therapeutic failure (Masterton et	al., 2006).
What is antimicrobial resistance?
Definition of resistance
The development of antimicrobial resistance 
can be seen as a global problem in microbial 
ecology and is the best-known example of a 
rapid adaptation of bacteria to a new ecosystem 
(Carattoli, 2001). Micro-organisms are ubiquitous 
in nature and there is a continuous exchange of 
genetic information between bacteria inhabiting 
diverse ecological niches including, humans, 
animals and the broader environment. Genetic 
exchanges, combined with the selection of 
partially-resistant microorganisms through 
continued exposure to sub-lethal doses of 
antibiotics, contribute to the emergence of 
groups of intermediate resistant and/or (clinically) 
resistant bacteria. The position of clones on the 
susceptible/intermediate/resistant continuum 
is generally defined on the basis of in vitro 
parameters, related to their ability to survive 
exposure to a defined concentration of an 
antimicrobial compound. Bacterial infections 
can be described as being clinically resistant 
if they have a low probability of responding to 
Introduction
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drug treatment, even if the maximum dose of 
the antimicrobial compound in question is given 
(EUCAST, 2000; Acar and Rostel, 2001). Degrees 
of antimicrobial susceptibility/resistance in 
clinical isolates are often defined in terms of 
the Minimum Inhibitory Concentration (MIC) of 
an antimicrobial compound required to prevent 
bacterial growth. 
Bacteria can be defined as being resistant to 
an antimicrobial compound, when its MIC is 
higher than its wild-type counterpart (EUCAST 
in 2000; Acar and Rostel 2001). For this reason, 
the ‘epidemiological cut-off values’ will vary 
among different species and geographical 
regions. Antimicrobial drug resistance can be 
defined under a number of headings as follows. 
A summary of the mode of action of some 
antibiotics is illustrated in Figure 1.
Figure 1 Mode of Antibiotic Action
Source:	(Madigan	et	al.	2000)
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Intrinsic resistance
Intrinsic resistance relates to the unique 
physiological properties of a micro-organism, in 
which their metabolic activity is substantially 
unaffected by the presence of an antimicrobial 
compound. For example, a bacterium may not 
possess a particular metabolic pathway, or 
internal structure, normally targeted by the 
antimicrobial compound. 
Such resistances are generally chromosomally 
encoded, and are typically responsible for 
observed differences in resistance observed 
between genera, species and strains of bacteria. 
Intrinsic resistance can be associated with 
differences in cell wall structures, the ability 
to pump antimicrobial compounds out of 
the bacterial cell using efflux pumps, or the 
production of enzymes capable of inactivating 
antimicrobial compounds within the bacterial 
cell (Russell, 2001; Gilbert and McBain, 2003). 
Gram-negative bacteria in general have a 
higher resistance to antimicrobials than Gram-
positive bacteria (Russell and Chopra, 1996). 
More specifically, Gram-negative bacteria are 
intrinsically resistant to penicillin G, a ß-lactam 
antibiotic, by virtue of their different structure, 
which prevents the antibiotic from accessing the 
cell wall. Intrinsic resistance is not considered a 
clinical problem because antibiotics were never 
intended for use against these resistant bacteria. 
Acquired resistance
Acquired resistance, in which a previously 
sensitive bacterium becomes resistant, can arise 
as a result of (a) a mutation in the organisms’ 
Deoxyribonucleic acid (DNA), or (b) through 
the acquisition of one or more antimicrobial 
resistance genes as a result of horizontal gene 
transfer within and between bacterial species. 
(a) Mutation in the organisms DNA
De novo emergence i.e. a mutation in the 
chromosomal DNA of a house-keeping structural 
or regulatory gene (Courvalin and Trieu-Cuot, 
2001) occurs approximately once in every one 
billion cell divisions (Pallasch, 2003). These 
mutations are associated with uncorrected errors 
arising during DNA replication. Although rare, 
such mutation events occur all too frequently 
against the background of the millions of on-
going bacterial replication processes in our 
environment. The vast majority of these errors 
are disadvantageous to the host bacterium, and 
do not persist at cellular or population levels. 
However, the smaller number of such genetic 
mistakes which are advantageous to the host 
bacterium can persist and, through a process of 
natural selection, emerge to confer resistance to 
many bacteria, presenting significant problems in 
clinical medicine. 
Emergence of antimicrobial resistance can be 
accelerated by several means. Thus, different 
members of a bacterial species will mutate at 
different rates (Martinez and Baquero, 2002), 
e.g. approximately one per cent of E.	coli 
exhibit a hypermutation phenotype (LeClerc et	
al., 1996; Matic et	al., 1997). The proportion of 
hypermutable strains is much higher in chronic 
infections, including cystic fibrosis, chronic 
stomach infections (Bjorkman et	al., 2001) and 
chronic obstructive pulmonary disease (Macia et	
al., 2005).
20
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(b) Horizontal gene transfer
Once antimicrobial resistance-conferring genes 
have appeared by mutation, they can be mobilised 
between strains and species by a processes 
of horizontal gene transfer. These processes, 
which can occur in the environment (in vitro) or 
during infection (in vivo), include conjugation, 
transduction and transformation, and can involve 
one or more defined genetic elements including: 
bacteriophages, plasmids, conjugative transposons 
and integrons (Carattoli, 2001). The detailed 
mechanisms of these processes are outlined later 
in this document and this could be appropriately 
regarded as a dynamic process wherein a pool of 
resistance genes is being actively shared across the 
prokaryotic kingdom.
In line with this view, the term ‘resistome’ has 
been coined recently to include all antimicrobial 
resistance-encoding genes present in the 
environment that are potentially transferable 
to pathogenic bacteria (D’Costa et	al., 2006). 
Therefore, it is important to recognise that 
many environments contain a wide range of 
non-pathogenic micro-organisms carrying 
antimicrobial resistant determinants, can 
potentially be transformed to sensitive pathogenic 
bacteria under appropriate conditions. This means 
that efforts to limit the acquisition of antimicrobial 
resistance by human pathogens must recognise 
the much wider resistance repertoire that may 
be encountered in sewage facilities, animal and 
human microbiota (Martinez et	al., 2007), foods 
and the food processing environments (Mc Mahon 
et	al., 2007; Walsh et	al., 2008).
Multi-drug resistance
Antimicrobial compounds are divided into 
different chemical classes (Figure 1), with each class 
containing a group of closely related compounds 
or their chemical derivatives, which all act in a 
similar manner in susceptible bacteria. Multi-drug 
resistance is defined as resistance to three or more 
individual classes of antimicrobial compound.
Cross-resistance and cross-selection
Cross-resistance occurs when a single 
biochemical mechanism confers resistance to 
more than one member of a group of related 
antibiotics (i.e. a class). Conversely, antibiotics 
belonging to different classes are structurally 
dissimilar, having different cellular targets and 
are, therefore, usually not subject to cross-
resistance. As a consequence, resistance is 
a class-based phenomenon since it affects 
the impact of antibiotics of a particular 
group, but not antibiotics belonging to other 
classes. However, cross-resistance between 
various antibiotic classes can also occur by 
two mechanisms, i.e., overlapping targets and 
increased drug efflux action (Courvalin and Trieu-
Cuot, 2001).
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Once antimicrobial resistance-conferring genes have appeared by mutation, they 
can be mobilised between strains and species...
Overlapping targets
Macrolides, lincosamides and streptogramins 
(MLS
B
, including streptogramin B) are 
chemically, if quite distantly related (Depardieu 
and Courvalin, 2001). However, constitutive 
methylation of a single adenine base in ribosomal 
RNA confers a high-level of resistance to all 
three classes of antibiotics (Fluit et	al., 2001). 
Clinically, the MLS antibiotics are used primarily 
for the treatment of a variety of Gram-positive 
infections, especially methicillin-resistant 
staphylococci (Zhanel et	al., 2001). The increasing 
appearance of MLS-resistant strains has 
compromised their treatment options in recent 
years and as a result many synthetic derivatives 
of the macrolides have had to be produced. 
Antibiotic efflux
A common mechanism in bacteria is an active 
export by membrane-bound efflux transporters 
(Poole, 2005; Piddock, 2006; Poole, 2007), by 
which bacteria eliminate antibiotics and other 
structurally unrelated chemicals, including 
dyes, bile salts, anticancer and antifungal drugs 
(Neyfakh, 2002). Antimicrobial resistance in over-
expressing efflux mutants can be attributed to 
two mechanisms, (a) an increase in the expression 
of efflux pump activity, or (b) through amino acid 
substitution(s), making the pump protein more 
efficient at exporting xenobiotic compounds 
(Piddock, 2006). Efflux also delays the death 
of the bacterium by lowering the intracellular 
antibiotic concentration (Yu et	al., 2003), thus 
providing the bacterium with additional time 
for mutation to occur (Courvalin and Trieu-Cuot, 
2001). Drug-specific efflux pumps have also 
been identified and these are usually associated 
with mobile genetic elements, which can be 
transferred between bacteria. In contrast Multi-
Drug Resistant (MDR) efflux pumps are generally 
chromosomally encoded (Poole, 2007). The broad 
substrate specificities of these efflux pumps 
accounts for the decreased susceptibility in 
some bacteria, to ß-lactams, aminoglycosides, 
chloramphenicol, fluoroquinolones, MLS
B
 drugs, 
tetracycline, trimethoprim, sulfonamides and 
other chemical compounds. It is well-established 
that MDR efflux pumps confer clinically relevant 
resistance to antimicrobial compounds in bacteria 
(Poole, 2005).
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Hazard identification
Antimicrobial resistance can be considered 
a direct hazard when the aetiological agent 
involved in infection is an antibiotic resistant 
food-borne pathogen. An indirect hazard arises 
though the transfer of resistance genes to 
another bacterium such as a commensal or 
pathogenic organism.
Relevance to food producing animals 
and human health 
Until recently antimicrobials have been added 
to feed and water to promote growth and limit 
infection in food-producing animals. Although, 
such supplementation poses minimal risk in 
terms of toxicity to the animal, it disturbs the 
normal animal flora. The risks associated with 
the development of antimicrobial resistance are 
increasingly recognised as significant (WHO, 
2008). A recent meeting between the Food 
and Agriculture Organisation (FAO), the World 
Organisation for Animal Health (OIE) and the 
World Health Organisation (WHO) (Geneva 
in 2003) concluded that the emergence of 
antimicrobial resistant organisms associated 
with non-human usage of antimicrobials posed 
adverse consequences to human health. More 
recently, new European Union (EU) regulations 
banning the use of antibiotics as growth 
promoters in animals have been introduced in an 
attempt to reduce the emergence of antibiotic 
resistance in the food-chain. 
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...the emergence of antimicrobial resistant organisms associated with non-human 
usage of antimicrobials poses adverse consequences to human health...
Such policies are in accordance with the WHO 
recommendations and Codex Alimentarius 
Commission guidelines. Many classes of 
antimicrobial compound(s) are currently used in 
both human and animal therapy, raising concerns 
about the possibilities of the development of 
resistance in animals, and the direct (contact) 
or indirect (food) transfer of such resistance to 
humans. Such concerns, coupled with the lack of 
newly developed antimicrobial drugs, have led to 
the necessity to establish management systems, 
to contain and if possible, prevent antimicrobial 
resistance. Regulatory measures such as 
restriction or banning the use of antimicrobial 
compounds for specific purposes, or in specific 
animal species, have also been established.
Two expert meetings convened by the WHO 
(2005, 2007) resulted in a classification system 
for antimicrobial drugs. Antimicrobial drugs 
were determined as ‘critically important’, ‘highly 
important’ or ‘important’ on the basis of the 
extent to which they were sole therapies: 
(i)  one of a limited number to treat serious 
human disease and 
(ii)  used to treat diseases caused by micro-
organisms that may be transmitted via 
non-human sources or diseases caused by 
microorganisms that may acquire resistance 
genes from non-human sources (see appendix 
for Table 1.)
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Resistant organisms, pathogenic to humans, have been recovered from food animals 
or their derived products...
2
Antimicrobial agent use in food animals 
as a cause of human illness
It has been postulated for some time that 
the use of antimicrobial compounds in food 
animals may contribute to the emergence of 
antimicrobial resistant-related health problems 
in humans (Bates, 1997). This hypothesis involves 
a number of causation steps a) conditions that 
facilitate antimicrobial resistance b) emergence 
of antimicrobial resistance in an organism 
pathogenic to humans c) human exposure to the 
resistant organism d) host susceptibility to the 
organism and e) virulence changes associated with 
antimicrobial resistance. 
There is on-going evidence supporting the 
hypothesis through each of the stages individually 
or across multiple stages. These are as follows: 
Causative steps in antimicrobial 
resistance
 Conditions that facilitate antimicrobial 
resistance 
Antimicrobial agents are widely used in 
food animal production for therapeutic and 
prophylactic use, as well as for growth promotion 
(Shea et	al., 2004). The use of sub-therapeutic 
doses in healthy animals for prophylaxis and 
growth promotion, coupled with imprecise 
dosages given to ill and healthy animals (by 
delivery of antimicrobials through feed or water), 
facilitates antimicrobial resistance though 
selection (Hamer, 2002; Wegener, 2003; Shea et	
al., 2004; Rosengren et	al., 2008).
Emergence of antimicrobial resistance in an 
organism pathogenic to humans
Resistant organisms, pathogenic to humans, have 
been recovered from food animals or their derived 
products, including: 
26
2 Antimicrobial agent use in food animals as a cause of human illness 
• Methicillin-resistant Staphylococcus	aureus	
(MRSA) isolated from cows milk (Leonard and 
Markey, 2008)
• MRSA in pigs (Armand-Lefevre et al., 2005, 
Huijsdens et al., 2006)
• resistant Salmonella	spp. on egg-shells (Little 
et al., 2006)
• resistant Salmonella	spp. in cow’s milk 
(Murphy et al., 2008) and in retail meats 
(including chicken, pork, turkey and beef) 
(White et al., 2001
• Chen et al., 2004) resistant	E.	faecium in 
chickens and pork (Sorenson et al., 2001); 
multi-drig resistant Campylobacter spp. in 
feedlot cattle (Minihan et al., 2006) and
• ß-lactam-resistant E.	coli, Salmonella	spp. and 
Staphylococcus	aureus in food animals (Li et	
al., 2007)
In the Netherlands the incidence of 
fluoroquinolone resistant Campylobacter	spp. 
increased from 0 to 14 per cent in broiler chickens, 
and from 0 to 11 per cent in farm workers, 
following the introduction of enrofloxacin and 
saxifloxacin on poultry farms (Hamer, 2002).
The emergence of Vancomycin Resistant 
enterococci (VRE) (Kayser, 2003) was attributed 
to the use of avoparcin, a growth promoter 
chemically related to the glycopeptide antibiotic 
vancomycin. In some instances the use of one 
antimicrobial compound may give rise to the 
development of a MDR phenotype, as several 
resistance genes may be linked and transferred 
together on a mobile genetic element, (Shea et	
al., 2004; Li et	al., 2007).
Human exposure to the organism 
Humans can be exposed to antimicrobial-
resistant bacteria through food derived 
from colonised animals, through increasing 
antimicrobial resistance in the environment and 
through food contamination during processing. 
Environmental contamination with resistant 
organisms, of surface waters for example, has 
also been reported, giving rise to concerns about 
direct exposure (Shea et	al., 2004). Numerous 
outbreaks of resistant infections associated with 
food animal sources have been reported, with 
some examples provided in Table 2:
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Humans can be exposed to AMR bacteria through food from colonised  
animals, antimicrobial resistance in the environment and food contamination 
during processing. 
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2 Antimicrobial agent use in food animals as a cause of human illness 
The 
N
etherlands
(H
uijsdens et 
al., 2006)
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Numerous outbreaks of resistant infections associated with food animal sources 
have been reported.
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2 Antimicrobial agent use in food animals as a cause of human illness 
Europe – 
Iceland, 
England &
 
W
ales, The 
N
etherlands, 
Scotland and 
G
erm
any
(Crook et al., 
2003)
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2 Antimicrobial agent use in food animals as a cause of human illness 
D
enm
ark
(M
olbak et al., 
1999)
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2 Antimicrobial agent use in food animals as a cause of human illness 
 Host susceptibility and host vulnerability to 
the organism
The normal host immune response offers 
considerable protection against many infections, 
but patients with compromised immune systems 
are more vulnerable to these illnesses. Extremes 
of age are a recognised risk factor associated 
with increased vulnerability, as are underlying 
illnesses, including chronic disease, and prior 
antimicrobial treatment (Shea et	al., 2004). 
Other host factors may include: a long hospital 
stay, intensive care unit stay, having a urinary or 
vascular catheter; and antibiotic therapy (Kayser, 
2003). Use of proton pump inhibitors was also 
found to be a risk factor for S. Typhimurium 
DT104 (OR11.2, 95% CI 3.9-31.9) (Doorduyn et	
al., 2006). No vaccines are currently available 
to protect humans against antimicrobial-
resistant organisms, including Salmonella	spp., 
Campylobacter spp. or MRSA (Chin, 2000). 
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No vaccines are currently available to protect humans against antimicrobial-
resistant organisms...
Virulence changes associated with anti-
microbial resistance
The development of an antimicrobial resistance 
has been linked with increased virulence in some 
pathogenic organisms. This observation may be 
explained by the fact that the genes encoding 
resistance and virulence are located on plasmids, 
or other transmissible elements (Foley and Lynne, 
2008). The use of antimicrobial compounds may co-
select for virulence in these cases (Molbak, 2005). 
Enterococci form part of the normal 
gastrointestinal flora of animals and humans 
and some of these organisms are used in the 
manufacture of food or as probiotics. More 
recently, however, enterococci have emerged as 
important nosocomial pathogens with some 
strains being resistant to several antimicrobials. 
Following the introduction of avoparcin, a 
glycopeptide growth promoter (chemically 
related to and conferring cross-resistance to 
vancomycin) in Europe in 1974, resistance to this 
agent began to emerge among isolates recovered 
from animals, the food supply and urban and 
rural sewage supplies (Bager et	al., 1997). This 
development is now linked with VRE in animals. 
These organisms can be transmitted from the 
intestinal tracts of animals to humans. Using 
molecular sub-typing approaches, an association 
has been demonstrated between the use of the 
growth promoter avoparcin in animals and VRE 
cases in humans.
Many antimicrobial resistant bacterial infections 
involve longer hospitalisations and increased 
mortality (Angulo et	al., 2004). The Centers for 
Disease Control and Prevention (CDC) review 
of 2004 provided evidence of the association 
between the use of antimicrobial agents in food 
animals and human illness (Angulo et	al., 2004). 
 Relationship between antimicrobial 
use in animals and human illness
The majority of the evidence acquired through 
outbreak and epidemiological investigations of 
sporadic infections, field studies, case reports, 
ecological and temporal associations and 
molecular sub-typing studies (Table 2) support 
the causal link between the use of antimicrobial 
agents in food animals and human illness. A few 
papers have questioned this but these have not 
survived detailed scrutiny. 
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37
Micro-organisms have developed seven major mechanisms to evade the 
bactericidal or bacteriostatic actions of antibiotics. 
Antimicrobial resistance
3
Mechanisms of antimicrobial 
resistance
Micro-organisms have developed seven major 
mechanisms to evade the bactericidal or 
bacteriostatic actions of antibiotics. These 
mechanisms are listed in Table 3 and the main 
mechanisms are illustrated in Figure 2. 
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3 Antimicrobial resistance 
Table 3 Mechanisms of antibiotic resistance.
(Adapted from Pallasch, 2003)
Enzymatic antibiotic inactivation 
ß-lactamases: ß-lactams (penicillins, cephalosporins) Acetyltransferases: aminoglycosides, 
chloramphenicol and streptogramins
Modification/ protection of target sites
Modified penicillin binding proteins: ß-lactams
Altered DNA gyrase and topoisomerase IV: fluoroquinolones
Altered RNA polymerase: Rifampin
Methylation of an adenine of 23S rRNA: erythromycin, clindamycin, streptogramins
Alteration of 16S rRNA: tetracyclines
Altered tetrahydrofolate and dihydrofolate reductase: sulfonamides and trimethoprim
Substitution of terminal peptidoglycan alanine with lactate: vancomycin and teicoplanin
Limiting antibiotic access to microbial cell
Altered outer membrane porins/reduced membrane transport: most antibiotics
Active efflux 
Antibiotic efflux proteins: tetracyclines, fluoroquinolones
Failure to activate antibiotic 
Decreased flavodoxin production: metronidazole
Development of alternate growth requirements 
Production of auxotrophs: enterococci
Overproduction of target sites
Hyper ß-lactamase production: enteric bacilli
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Horizontal gene transfer may occur by various mechanisms including conjugation, 
transduction and transformation.
Figure 2 Mechanisms of microbial resistance to antibiotics
Adapted	from:	(Levy,	1998),	a)	efflux	pumps,	b)	antibiotic	degrading	enzyme	and	c)	antibiotic	altering	enzyme
Mechanisms of transmission-Horizontal  
gene transfer
Transfer may occur by various mechanisms 
including conjugation, transduction and 
transformation (see Figure 3). In addition, the 
contribution of transposable elements and 
integrons linked to plasmids has been reported 
(Carattoli, 2001). Transposons and integrons 
accelerate the development of bacterial resistance 
by assisting in the accumulation, expression and 
dissemination of resistant genes. 
These features support the onward transmission 
of antibiotic resistance genes to daughter cells 
by replication or transfer within or among 
other bacterial species, typically by conjugation 
(Carattoli, 2003).
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3 Antimicrobial resistance 
Figure 3 Transferable antibiotic resistance mechanisms in bacteria
Adapted	from:	(Levy,	1998),	(a)	conjugation,	(b)	transduction	and	(c)	transformation
Plasmid
A plasmid is an extrachromosmal genetic 
element, which can maintain and express genes 
of interest, similar to the chromosome. However, 
the genes encoded on a plasmid are not usually 
present on the bacterial chromosome and 
typically confer a specialised function (i.e. an 
R-plasmid confers antimicrobial resistance), which 
can improve the cell's adaptability, survival and 
growth (Martinez and Baquero, 2002). 
Plasmids also have the ability to multiply 
independently of the bacterial chromosome and, 
in many cases, contain the necessary information 
for their independent transfer from cell to cell, 
between and among different species and genera 
of bacteria (Wilson, 2000). Thus, the original 
host may retain some of the multiple plasmids, 
while one or more copies can be transferred 
to additional recipient host bacterial cells. 
Antibiotic resistance is carried on sections of 
plasmids called transposons, or jumping genes. 
Transposons are able to jump out of one plasmid 
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Antibiotic resistance is carried on sections of plasmids called transposons, or 
jumping genes. 
and into another, carrying antibiotic resistance 
with them (Carattoli, 2003). They can also jump 
from a plasmid to the bacterial chromosome 
and back again. By this means, plasmids can 
accumulate resistance to an increasing number of 
antibiotics, which are then easily available to be 
transposed within and between bacterial species. 
Conjugation
Conjugation requires the donor to have a 
particular type of plasmid or a transposon to 
mobilise the donor DNA, recognise/bind a 
suitable recipient and transfer the gene(s) of 
interest (Day, 1998). There are four different 
classes of plasmid-borne integrons that carry 
antibiotic resistance genes. Each integron 
carries a distinct integrase gene, of which class 
1 integrons are the most common. The 3’-ends 
of class 1 integrons usually carry sul1, a gene 
coding for sulfonamide resistance. This class of 
integron can carry a varying number of up to nine 
gene cassettes. Class 2 integrons are different 
and usually carry three gene cassettes (dfr1a,	
sat1,	aadA1), which include a dfr gene encoding 
trimethoprim resistance. 
Co-trimoxazole resistance is reported to signal 
the presence of integrons (Leverstein-van Hall et	
al., 2003). Strains with integrons have a higher 
chance of being resistant to aminoglycosides, 
quinolones and ß-lactams. Class 3 and 4 
integrons have only been observed in a few 
cases in Japan and India, respectively. Integrons 
have the ability to capture genes, notably those 
encoding antibiotic resistance by site-specific 
recombination (Carattoli, 2003). Integrons have 
an integrase gene (int), a distal recombination 
site (attl) and a promoter (Pant), which flanks 
a central region wherein gene cassettes are 
recombined (Hier et	al., 2004). More than 60 
different gene cassettes have been identified, 
with some integrons possessing multiple 
cassettes arranged in tandem and recombined in 
a classical head-to-tail	orientation (Mazel et	al., 
2000). As these resistance determinants are under 
the control of a single promoter all recombined 
gene cassettes are subsequently co-expressed. 
Thus, selective pressure for one determinant by 
the use of a particular antibiotic, will co-select for 
resistance determinants encoded by downstream 
cassettes. This is also important in light of the 
fact that integrons (and also transposons) have 
been shown to possess a number of genetic 
determinants encoding resistance to Quaternary 
Ammonium Compounds (QACs) and heavy 
metals (Olsen, 1999). This suggests the possibility 
that, exposing integron-carrying bacteria to 
sub-inhibitory levels of QACs, may co-select for 
antibiotic resistant bacteria in the absence of 
antibiotics (White et	al., 2003).
Transduction
Transduction is the movement of DNA from one 
bacterium to another via bacteriophages (bacterial 
viruses). This usually occurs when a virus picks up 
resistant DNA from one bacterial cell and injects 
it into another (Smyth et	al., 2003). Phage particles 
can protect DNA during transfer, as they generally 
show higher levels of resistance to adverse 
environmental conditions than free DNA (Day, 1998).
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3 Antimicrobial resistance 
Transformation
Transformation is an active and dedicated process 
of gene exchange, governed by chromosomal genes 
that allow the uptake of exogenous free DNA by 
a competent cell (Smith et	al., 2003). Competence 
is often a transient and tightly-regulated process, 
through which a proportion of a population passes 
due to physiological changes occurring within 
those populations (Day, 1998). It is a mechanism 
of widespread, but not universal, gene exchange 
among bacterial strains (Wolfgang et	al., 1999). 
Many transformable bacteria release DNA during 
growth. Thus, at least 50 different bacteria have 
been demonstrated as competent to acquire 
genes released into the environment from other 
microbes, plants, yeasts and animals (Havarstein, 
1998). Genes gained following transduction and/or 
transformation must be integrated into a plasmid or 
chromosome to be functional (Levy, 1998).
Effect of food processing 
technologies
The frequent isolation of MDR isolates from food 
sources, suggests that antibiotic resistant genes 
are present in a wide variety of different bacterial 
species found in food. This raises the question 
as to whether or not antibiotic resistance and 
sensitive bacteria respond differently to food 
processing stresses like heat and acid (Humphrey, 
2001). Does antibiotic resistance confer cross-
resistance to other food-related stresses, or 
does it impose a fitness cost, making antibiotic 
resistant cells more susceptible to such stresses? 
Increased resistance to low pH environments 
would raise concern about the stability and 
safety of dairy and fruit juice products. Increased 
resistance to thermal stress would be of concern 
in relation to a wide range of mildly heat-treated 
foods, in particular meat products. Accurate 
information on potential changes in response 
to food processing parameters is especially 
important when considering low infectious 
dose pathogens, such as, E.	coli O157, where 
the presence of even a small number of cells 
could be clinically significant. Very little data 
is available in this area and the small number 
of reports available present conflicting results. 
This is unfortunate, as accurate information is 
essential to allow food processors to effectively 
eliminate undesirable pathogens from food, with 
minimum damage to the nutritional, organoleptic 
and visual properties of the product. Precise 
processing parameters may be necessary to gain 
the best possible balance between food safety 
and food quality.
A further concern is that sublethal food 
processing stress could play a role in the 
development and persistence of antibiotic 
resistance/MDR, through the action of the 
Multiple Antibiotic Resistance operon or by 
increasing the rate of horizontal plasmid transfer 
(including MDR plasmids). For example, food 
processing-related stresses can cause increases in 
DNA damage, reductions in the efficiency of DNA 
repair and increases in membrane permeability. 
It is speculated that these stresses can result in 
the development of antibiotic resistance within 
the bacterial cell, including the release/transfer 
of antibiotic resistant determinants to other cells 
(Lado and Yousef, 2002). The current evidence for 
these concerns will be discussed in detail later in 
this report.
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The frequent isolation of MDR isolates from food sources, suggests that antibiotic 
resistant genes are present in a wide variety of different bacterial species found  
in food.
Antimicrobial resistance and bacterial fitness
The development and/or acquisition of AMR 
enables host cells to survive in otherwise hostile 
(antimicrobial containing) environments. The more 
chromosomal and/or plasmid-borne genes the 
host carries, the more energy it has to expend in 
maintaining and replicating this heavier compliment 
of genes, making the host less efficient and 
generally less competitive compared to susceptible 
cells carrying fewer resistance genes. Such 
reductions in bacterial	fitness can for example, 
reduce host growth rates, leading to overgrowth 
by leaner, antibiotic susceptible strains. However, 
slower growth is also related to increased resistance 
to other unrelated environmental stresses, including 
those used in food processing (McMahon et	al., 
2007). It is therefore possible that the increasing 
incidence of AMR may have significant implications 
for the food production and processing industry, 
by reducing the efficiency of food preservation 
techniques, and reducing current safety margins 
within the food industry. AMR-associated 
increases in resistance to common food processing 
interventions, such as the application of low/high 
temperature, water activity (a
w
) reduction or pH 
modulation is of particular concern in the safe 
production and preservation of minimally-processed 
foods. Such foods, which form an expanding 
fraction of our total food supply, are welcomed by 
consumers as fresh and natural. However, these 
operate within fairly narrow margins of safety which 
could be breached by the slight increases in bacterial 
resistance to environmental stress which may be 
associated with the acquisition of a resistance 
marker. This means that accurate up-to-date 
information on antimicrobial resistance and their 
impacts on bacterial fitness are essential to assure 
safe food processing and preservation schemes.
A number of studies have reported that 
chromosomal AMR mutations, do not confer a 
fitness cost during growth (Gustafsson et	al., 
2003), heat treatment (Walsh et	al., 2001; Duffy et	
al., 2006; Walsh et	al., 2006), or at low pH (Tkalcic 
et	al., 2000). However, other studies suggest that 
some chromosomal AMR strains do incur a small, 
but observable, fitness cost (Sander et	al., 2002). 
Fitness costs have also been observed during 
growth (Blackburn and Davies, 1994; Gustafsson 
et	al., 2003), heat treatment (Doherty et	al., 1998) 
and survival at low pH (McGee, 2003) in a variety 
of different strains although such fitness costs 
may decline (partially or totally) in subsequent 
bacterial generations. For this reason fitness 
costs incurred during the initial development 
of resistance, may be rapidly reduced by 
compensatory mutation (Maisnier-Patin et	al., 
2002). Such compensation has been reported to 
occur in either in	vivo	or	in	vitro studies (Björkman 
et	al., 2000; Reynolds, 2000). Other studies report 
compensation through a variety of secondary 
mutations, resulting in increased fitness (over-
compensation), i.e. the emergence of organisms 
with enhanced survival characteristics (Reynolds, 
2000) including superior growth rates (Ince and 
Hooper, 2003) and virulence (Bjorkman, 1998). 
The relationship between AMR and fitness will be 
discussed further for each foodborne pathogens 
in this report.
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Salmonella enterica is a major cause of bacterial enteric illness in humans  
and animals... 
Specific organisms
4
Salmonella – Major pathogenic 
bacterial hazards
Non-typhoidal Salmonella
Introduction
Salmonella	enterica is a major cause of bacterial 
enteric illness in humans and animals and is 
notably the second leading cause of zoonotic 
infection in the European Union (Gupta et	al., 
2004). Human infection can also be acquired 
through direct contact with carrier domestic 
or wild animals, or through consumption of 
contaminated foods. 
Description of species
Salmonella	spp. are Gram-negative, facultatively 
anaerobic rods, which are usually motile by 
peritrichous flagella. Their optimal growth 
temperature is 37 C˚, during which D-glucose 
and other carbohydrates are metabolised with 
the production of acid and (usually) H2S gas. 
However, they do not utilise urea (Holt et	al., 
1994). Salmonella	spp. are oxidase negative, 
catalase positive, indole and Voges-Proskauer 
negative, methyl red and Simmons citrate 
positive (Madigan et	al., 2000). They are readily 
killed by heat and acid and are resistant to both 
freezing and drying, particularly in the presence 
of proteins and protectants. This genus prefers 
pH values between 4 and 8 and requires a water 
activity of 0.93 and above (Baird-Parker, 1990). 
They are found to occur in humans, warm and 
cold blooded animals, food and the environment. 
They are pathogenic to humans and many 
other animal species (Tietjen and Fung, 1995). 
The infectious dose can be as few as 15-20 cells, 
depending on age, health of the host and strain 
differences among the members of the genus. 
Salmonella	spp. can cause typhoid fever, enteric 
fever, gastroenteritis and septicaemia (Holt et	al., 
1994). 
Salmonella	in food on the island of Ireland
In 2006, 1.3 per cent of the raw poultry meat 
tested at the processing level was positive for 
S.	enterica, followed by 5.3 per cent in 2007. 
This slight increase was the first observed 
since Salmonella	spp. contamination rates were 
reported to be declining in 2001. This increase was 
not mirrored in poultry meat products, as 
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only a marginal difference (0.2%) was evident 
between 2006 (0.3%) and 2007 (0.5%). No 
contamination was reported at retail level in 2006 
and very low levels of contamination (0.1%) were 
observed similarly in 2007 (Table 4). The most 
frequently isolated serotypes from poultry meat 
and associated products in 2006, were S.	Agona 
(16%), S. Kentucky (15%) and S. Mbandaka (15%), 
followed by S. Kentucky (75%), S.	Agona (10%) and 
S. Enteritidis (4%) in 2007.
S.	enterica was not isolated from any of the 
1,190 egg or egg products sampled in 2006. In 
2007, one isolate (0.1%) of the 809 egg and egg 
products sampled, was found to be positive for 
Salmonella	spp. (S.	Agona) (Table 4). 
S.	enterica was identified in 1.7 per cent of raw 
pork and 0.5 per cent of pork products sampled 
at processing in 2006. Higher rates of recovery 
were observed at a processing level in 2007, as 
2.9 per cent of raw pork and 0.7 per cent of pork 
products tested positive for S.	enterica (Table 4). 
S.	Typhimurium was the most frequently isolated 
serotype from pork and pork meat products in 
2006 and 2007 (48% and 45% of all the serotypes 
identified, respectively) (FSAI Zoonosis Report 
2009). A relatively low proportion (0.06 to 0.2%) 
of beef, veal and associated products were 
found to be contaminated with	S.	enterica at the 
processing level, compared to none at the retail 
level in 2006 and 2007 (Table 4). Of the S.	enterica	
isolates recovered, S.	Typhimurium (37% of 
serotypes in 2006 and 34% in 2007) and S. Dublin 
(37% of serotypes in 2006 and 20% of 2007) were 
the most predominant serotypes recovered in 
both years (FSAI Zoonosis Report 2009). In 2006 
and 2007, a low incidence (0.01 to 0.8%) of S.	
enterica was recovered from other meat and meat 
products at the processing level, and none at 
retail. S.	Typhimurium was found to make up 32 
and 22 per cent of the S.	enterica	strains isolated 
in 2006 and 2007, respectively (Table 4).
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Salmonella most commonly isolates from raw poultry meat compared to 
other meats.
Table 4 Salmonella	spp. in food products in the ROI 2005
Food type Sampling site Tested 2006 Positive 2006 Tested 2007 Positive 2007
Poultry
Raw poultry 
meat*
Processing 
level*
Retail level
6,477
8
84  
(1.3% 0)
5,976
4
319 (5.3%)
0
Poultry meat 
products
Processing 
level
Retail level
6,698
1,378
22 (0.3%)
0
5,578
1,281
27 (0.5%)
1 (0.1%)
Eggs & Egg Products
Table eggs 148 0 104 1 (0.1%)
Egg products 1042 0 1667 0
Pork & Pork Products
Raw pork meat Processing 
level
2,929 51 (1.7%) 2,015 58 (2.9%)
Pork meat 
products
Processing 
level
Retail level
9,053
943
46 (0.5%)
1 (0.1%)
9,111
951
59 (0.7%
0 (0%))
Beef & Veal
Raw beef /veal 
meat
Processing 
level
Retail level
21,644
3
36 (0.2%)
0
23,003
38
27 (0.1%)
0
Beef/veal meat 
products
Processing 
level
Retail level
13,783
491
25 (0.2%)
0
13,768
389
8 (0.06%)
0
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Other meat & meat products 
Fresh Meat
Sheep meat
 Sheep meat 
  Unspecified 
meat 
  Unspecified 
meat
Processing
Retail
Processing
Retail
1,506
2
2,273
2
2 (0.1%)
0
21(0.8%)
0
1,532
0
3498
0
2 (0.1%)
0
13(0.4%)
0
Meat Products 
Sheep meat
 Sheep meat 
  Unspecified  
 Unspecified 
Processing
Retail
Processing 
Retail
781
57
5,540
332
0
0
1(0.01%)
0
782
35
5035
361
0
0
9(0.2%)
0
(Source:	FSAI,	2009)	
Epidemiology of Salmonella	spp. on the island of 
Ireland and in Europe
In 2007, there were 456 reported cases of 
salmonellosis (10.8 cases/100,000 population) 
in the Republic of Ireland (ROI), indicating a 
small increase in incidence from 2006 (10.0 
cases/100,000 population) (HPSC, 2009). The 
highest age-specific incidence rate was in 
children 0-4 years of age (35.7 cases/100,000 
population) with 24 per cent of all cases occurring 
in this age-group. As in previous years, cases 
peaked between July and October. 
In Northern Ireland (NI), 159 cases of salmonellosis 
were confirmed in 2007 and 186 cases in 2008 
(provisional data) (CDSCNI, 2009). 
In Europe, 151,995 cases of salmonellosis were 
reported in 2007 (31.1 cases/100,000 population), 
showing a 7.3 per cent decrease from the previous 
year (EFSA, 2009). As seen for the ROI, the highest 
age-specific incidence rate was found in children 
aged 0-4 years of age (125.4 cases/100,000 
population).
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In Europe 151,995 cases of salmonellosis were reported in 2007, the highest age-
specific incidence rate was found in children 0-4 years of age.
Serotypes
S.	Enteritidis (n=179) and S.	Typhimurium (n=114) 
remain the two most predominant serotypes 
(39% and 25% respectively) involved in human 
illness in the ROI in 2007. Other serotypes 
included; S.	Newport (n=13), S.	Kentucky (n=9), 
S.	Typhi (n=8), S. Java (n=8) and S. Infantis (n=8). 
Eight isolates of S.	Typhi and five of	S. Paratyphi 
A isolates were detected in 2007, as opposed to 
seven S.	Typhi isolates and one S.	Paratyphi A 
isolate in 2006.
In NI (and the UK) the most common serotypes 
in human infection were S. Enteritidis and 
Typhimurium (EFSA 2006). In the EU, S. Enteritidis 
was reported at 65 per cent and S.	Typhimurium 
at 17 per cent of cases (EFSA, 2009). 
Food
The National Reference Laboratory (NRL) 
(Department of Agriculture Fisheries and Food, 
2008) for Salmonella	spp. typed 1,475 isolates of 
Salmonella	spp. in 2007. These were recovered 
through official control programmes or submitted 
by private laboratories supporting food safety 
controls operated by food business operators. Of 
the isolates detected, S. Kentucky was the most 
prevalent (n=612), followed by S. Typhimurium (195), 
S. Derby (99) and	S. Agona (93), with 26 strains of	S. 
Enteritidis also being isolated. 
However, the most recent UK wide outbreak of 
salmonellosis (148 cases to date, September 2008) 
was caused by S. Agona which was present in a 
range of contaminated sandwich fillers supplied 
by a single food company. This outbreak became 
Europe-wide, matching the distribution of 
contaminated material (www.hps.scot.nhs.uk).
The serotypes most commonly isolated from 
animals are species dependent (Table 5), with S. 
Dublin the most prevalent serotype in cattle, S. 
Diarizonae in sheep, S.	Livingstone in chickens and 
S. Typhimurium in pigs. S. Rissen and S.	Mbandaka 
are the serotypes most commonly isolated from 
animal feed-stuff, however S.	Typhimurium, S.	
Enteritidis and S.	Hafar have been isolated on a few 
occasions (DEFRA, 2006). Although the Salmonella	
spp. serotypes most commonly associated 
with human salmonellosis are not the most 
prevalent serotypes found in animals, the fact 
that pathogenic Salmonella	spp. serotypes can be 
cultured from animals is a cause for concern and 
perhaps suggests that there may be a connection 
via the food chain or via animal contact.
In the EU, isolates from meat were commonly 
resistant to ampicillin, nalidixic acid, 
streptomycin and tetracycline with variations in 
the levels of resistance in food animals, being 
reported in different member states (EFSA, 2006).
50
4 Specific organisms
Table 5 S.	enterica	serotypes present in UK animals and food. (Adapted from Ong et al., 2007)
Source Prevalent Salmonella	
spp.
serotypes (% isolates 
reported)
% resistant to antibiotics
Fully SS  Te  Chl  3rd  Cip  Amino
 Ceph.  glycocides
Human 
infection
Enteritidis (68%) 
Typhimurium (20.8%)
72.3$ 7-38%* 1-4%* 8-15% 0-98%*
Chicken 
UK
Livingstone (17.5%) 
Senftenburg (12.3%)
44% 22% 8% 0% <1% 22%
Cattle UK Dublin (60.5%)
Typhimurium (21.5%)
73% 20% 18% 0% 0% 12%
Sheep UK Diarizonae (71.4%)
Typhimurium (8%)
92% 81% 47% 0% 0% 63%
Turkey UK Typhimurium Derby 50% 39% 14% 0% 0% 31%
Pig UK Typhimurium (66.2%)
Derby (13.9%)
11% 81% 47% 0% 0% 63%
Retail eggs 
non-UK
Enteritidis (3.3%)
Retail eggs 
UK
Salmonella	spp (0.38%)
Feedstuff Rissen, Mbandaka
Fully	SS	=	susceptible	to	all	antimicrobials	examined		
Data	consolidated	from	DEFRA	2006,	with	additional	information	from	
*	AMR	2004
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The emergence of MDR in Salmonella	spp. is considered an important evolutionary 
step in the epidemiology of salmonellosis. 
Recent surveys for the presence of Salmonella	
spp. on raw meat products in NI indicated a 
high incidence of Salmonella	spp. (40%) on 
post-eviceration pig carcasses (McDowell et	al., 
2007). A study of the prevalence of Salmonella	
spp. in the pork chain on the island of Ireland, 
reported that, Salmonella	spp. was recovered 
from 24 of 720 (3.3%) pork cuts in boning halls 
of pork abattoirs in the ROI and from 44 of 525 
(8.38%) of pork cuts in NI. The difference in 
prevalence in both jurisdictions was not found to 
be statistically significant. Furthermore, a study 
of the prevalence of Salmonella	spp. on retail 
pork cuts found Salmonella	spp. present in 13 of 
500 (2.6%) pork samples purchased in butchers 
shops or supermarkets in ROI. In comparison, 
Salmonella	spp. was recovered from 11 of 200 
(5.5%) pork samples purchased in butchers 
shops or supermarkets in NI. S.	Typhimurium 
(approximately 50%) and S.	Derby (approximately 
20%) were the most dominant serotypes.
A recent report noted that four per cent of raw 
chicken contained Salmonella	spp. in retail raw 
chicken in NI, (Meldrum and Wilson, 2007). In 
contrast to an earlier study by Soultos et	al. 
(2003), this report represents an increase of 1.5 per 
cent. The incidence in beef is unknown (no data 
available), although Salmonella	spp. were recently 
isolated from three per cent of faeces from post-
slaughter (healthy) cattle (Madden et	al., 2007). No 
data is available on the incidence of Salmonella	
spp. in eggs in NI, although it is thought to be 
low with similar rates to those reported in the 
UK – a direct result of the widely-adopted flock 
vaccination regime. A recent survey of Salmonella	
spp. in eggs on the island of Ireland, reported only 
two isolates (S.	Infantis, S.	Montevideo on egg 
shells) recovered from 30,000 samples (Murchie 
et	al., 2007), confirming that domestic (UK/Irish) 
produced eggs are currently unlikely to present a 
significant source of human salmonellosis.
Antimicrobial resistance in Salmonella	spp.
Salmonella	enterica continues to be an important 
cause of gastroenteritis with an increase reported 
in the ROI, NI, England and Wales in the year 
2007. S.	Typhimurium DT104 is perhaps the best-
known and most widely studied serotype of 
Salmonella	spp. because of its MDR phenotype. 
The emergence of MDR in Salmonella	spp. is 
considered an important evolutionary step in 
the epidemiology of salmonellosis. Until recently 
S.	Typhimurium DT104 could be distinguished 
from other Salmonella	spp. isolates, by the 
presence of Salmonella	genomic Island (SgI1). This 
genomic island, typically confers resistance to 
five antimicrobials (ampicillin, chloramphenicol, 
streptomycin, sulphonamides and tetracycline; 
ACSSuT) and has the ability to capture and stably 
maintain additional genes, encoding other 
antibiotic resistance determinants. As the SgI1 is 
chromosomally located, it is stably maintained 
in the absence of selective pressure. This feature 
continues to drive the emergence of new 
variants of S.	Typhimurium DT104 with reduced 
susceptibility to a larger repertoire of antibiotics. 
Moreover, the presence of the SgI1 is linked to 
higher rates of morbidity/mortality (Mulvey et	al., 
2006). Recent reports of the dissemination of SgI1 
among other serotypes of Salmonella	spp. and 
Proteus are alarming, particularly with regard to 
major pathogens of the developing world, such 
as, S.	paratyphi	(Velge et	al., 2005). The presence 
of the SgI1 limits therapeutic options, particularly 
in the developing world where chloramphenicol 
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Table 6 AMR of human	S.	enterica serotypes isolated in the ROI 2006. (Adapted from EPI-Insight, 2007a)
% Of Isolates Resistant to Antibiotics
Serotype (No. Isolates) AMP CHL STREP SULPH TET TRIM NAL
Enteritidis (158) 8 0.6 2 2 0.6 0.6 0
Typhimurium (101) 69 58 64 68 66 6 6
Agona (5) 20 0 20 40 20 0 40
Virchow (10) 30 20 30 60 50 60 100
Hadar (11) 45 0 100 18 100 18 45
Stanley (6) 33 0 50 50 50 33 0
Typhi (7) 43 43 43 43 0 43 57
Kentucky (4) 25 0 25 25 25 0 25
Bredeney (6) 0 0 0 0 0 0 0
is the antibiotic of choice as it is cheap and broad 
spectrum. 
Many S. Typhimurium isolates recovered in the 
ROI in 2007, were found to have a resistance 
profile typical of that conferred by the presence 
of the SGI-1 (63% resistant to ampicillin, 64% 
to sulphonamide, 71% to tetracycline, 61% to 
streptomycin and 42% to chloramphenicol). 
In comparison, for NI, there is no recent data 
available for antimicrobial resistant profiles. 
Reports in the EU found similar resistance profiles 
(ACSSuT) in Salmonella	spp., with additional 
resistance to the quinolones and nalidixic acid 
(EFSA, 2008).
MDR is prominent in the Salmonella	spp. 
population in the ROI (see Table 6). Reports of 
antibiotic resistance in clinical samples in the ROI 
confirms that MDR resistance in	S. Typhimurium 
is a growing problem, with resistance to 
trimethoprim and nalidixic acid also emerging. 
Similar resistance profiles are appearing in other 
serotypes (S. Stanley and S. Typhi), mostly likely 
as a result of transfer of the SgI1 (see Table 6).
53
Reports of antibiotic resistance in clinical samples in the ROI confirms that MDR 
resistance in S. Typhimurium is a growing problem...
With regard to the western world, the 
emergence of resistance to extended spectrum 
cephalosporins (antibiotics used in the treatment 
of complicated Salmonella	spp. in infants) is cause 
for concern. Extended spectrum celphalosporin 
resistance was first identified in S.	Virchow in 
Belgium, resulting in a national increase in the 
prevalence of	S. Virchow. Approximately one year 
after detection of this phenotype, this strain 
was isolated from poultry meat and humans. 
This strain was also resistant to tetracyclines, 
sulphonamides, trimethoprim and nalidixic acid 
in Europe and in the ROI (Table 7). The emergence 
of resistance to nalidixic acid is also of concern 
since it is the first step of a two-step mutational 
resistance to fluoroquinolones, the first choice 
antibiotics for treatment of Salmonella	spp. 
infection in adults. 
The emergence of cephalosporin resistance can 
be seen in many Salmonella	spp. serotypes in 
Europe including S. Agona, S. Derby, S.	Paratyphi 
B, S.	Typhimurium and of particular concern S.	
Infantis. While typically S. Infantis is reported to 
be resistant solely to cephalosporins, resistance 
is located on a transposon on a self-transmissible 
plasmid, indicating the possibility of 
dissemination to other serotypes. In conjunction, 
cephalosporin resistance is most prevalent in S.	
Infantis in poultry.
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Table 7a Antimicrobial susceptibility testing of Salmonella	spp. in animals in the ROI
N = Number of resistant isolates
 S. Typhimurium
Isolates from a monitoring 
programme
Cattle 
(bovine 
animals)
Pigs Gallus 
(fowl)
Turkeys Other animals 
– Clinical 
investigations
Number of isolates available 
in the laboratory
8 0.6 2 2 0.6
Antimicrobials: 69 58 64 68 66
Tetracyclin 20 0 20 40 20
Florfenicol 30 20 30 60 50
Cefalexin 45 0 100 18 100
Neomycin 33 0 50 50 50
Trimethoprim + sulfonamides 43 43 43 43 0
(Source:	Modified	from	EFSA,	2006a)
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In the western world the emergence of resistance to extended spectrum 
cephalosporins is cause for concern.
Table 7b Antimicrobial susceptibility testing of Salmonella	spp. in animals in the ROI
N = Number of resistant isolates
 S. Typhimurium
Cattle 
(bovine 
animals)
Pigs Gallus 
(fowl)
Turkeys Other animals 
– Clinical 
investigations
Other animals 
– Clinical 
investigations
Isolates out of a monitoring 
programme
- - - -
Number of isolates available 
in the laboratory
268 15 - 0
Antimicrobials: N n N n N n N n N n N n
Tetracyclines Tetracyclin 220 20 15 12 - - 0 0 13 3 2 1
Amphenicols Florfenicol 218 25 15 2 - - 0 0 13 2 3 0
Cephalosporins Cefalexin 41 4 6 0 - - - - 3 2 3 0
Fluoroquinolones 
Enrofloxcin
221 2 15 0 - - - - 13 0 3 0
Aminoglycosides 
Streptomycin Neomycin
41 10 7 7 - - - - 3 3 3 0
169 8 9 4 - - - - 8 1 3 0
Trimethoprim + 
sulfonamides Trimethoprim 
+ Sulfonamide
223 12 15 10 - - - 13 1 3 0
Resistant to 1 anitmicrobial - 26 - 3 - - - - - - - 1
Resistant to 2 anitmicrobials - 23 - 2 - - - - - - - -
Resistant to 3 anitmicrobials - 7 - 3 - - - - - 2 - -
Resistant to 4 antimicrobials - 1 - 2 - - - - - 1 - -
Resistant to > 4 
antimicrobials
- 2 - 4 - - - - - 1 - -
(Source:	Modified	from	Table	P54,	EFSA,	2006a)	
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Antimicrobial resistance in Salmonella	spp. in 
Northern Ireland 
Much of the recent NI-specific data is consolidated 
into the Health Promotion Agency Reports (HPA, 
2008) which have noted a generalised increase in 
antibiotic resistance in Salmonella	spp. isolates 
from diseased animals, environment and feed-
stuffs. However, a recent survey of Salmonella	
spp. isolated from post evisceration pig carcasses 
and caecal contents, indicated a high incidence 
of S.	Typhimurium in caecal contents (19%) and 
on carcasses (24%) (McDowell et	al., 2007). The 
majority of these were S.	Typhimurium (DT104) 
carrying the genomic island SgI1. McDowell et	al. 
(2007) reported high rates of resistance to these 
antibiotics (>50%) but low or no resistance to other 
clinically important antibiotics, such as, naladixic 
acid (2.1%), ciprofloxacin (0%) and cefotaxime 
(0%). The frequency of AMR in human enteric 
salmonellae in NI is high. However, it is not as high 
as reported in animal isolates for example, ACSSuT 
(26- 27%) and nalidixic acid (16%) and much lower 
for re ciprofloxacin and cefotaxime (< 1%) (Ong 
et	al., 2007). The increased level of resistance to 
nalidixic acid (caused by single point mutation) 
is of clinical importance (Stevenson et	al., 2007). 
The AMR profiles of Salmonella	spp. differ among 
food animal species. Porcine isolates tend to be 
resistant to a greater number of antibiotics than 
bovine or ovine, and turkey isolates are resistant 
to a greater number of antibiotics than chicken 
isolates (Table 7). No resistance to third generation 
cephalosporins or ciprofloxacin have been 
detected in any animal isolates, with the exception 
of one case in poultry. This is an important as 
ciprofloxacin is the drug of choice (DEFRA, 2006). 
Such intra-species differences may reflect on the 
intensity of the farming methods, for example, 
pigs are intensively reared indoors, where illness 
in one animal is easily spread through the herd. 
The whole herd may thus be treated, whereas 
cattle or sheep are field farmed and are treated as 
individual animals. The age of the infected animal 
is also important. Salmonella	spp. from calves 
for instance, are significantly more resistant to 
antibiotics than from older bovine animals (EFSA, 
2006), although the reasons for this are unclear.
Evidence of food processing impacts
Increased thermotolerance in an MDR strain 
of S. Typhimurium DT104 (in comparison with 
antibiotic-susceptible strains of S. Typhimurium) 
is of concern. Previous reports have speculated 
on the mechanisms and implications of S. 
Typhimurium DT104 possessing increased fitness/
survival characteristics, including thermal 
tolerance, by overcompensation of fitness costs 
or an increase in rpoS	expression (EUCAST, 2000; 
Humphrey, 2001). Walsh et	al. (2001) reported no 
difference in heat resistance between antibiotic-
susceptible and laboratory-acquired antibiotic 
resistant (nalidixic acid and streptomycin) strains 
of S. Enteritidis and	S.	Typhimurium at 55°C in 
chicken meat. However, the same study reported 
that MDR S.	Typhimurium DT104 was significantly 
more heat resistant at 55°C in chicken meat, 
than the antibiotic-susceptible strains of	S.	
Typhimurium and S.	Enteritidis. A subsequent, 
larger study by Bacon et	al. (2003a, 2003b) which 
examined five MDR and five antibiotic-susceptible 
strains including S.	Typhimurium DT104 (at 55°C, 
57°C, 59°C and 61°C in tryptic soy broth, with and 
without glucose), reported no difference in heat 
resistance between antibiotic-susceptible and 
MDR Salmonella	spp. isolates. When antibiotic 
resistance is induced, some strain variations in 
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acid resistance were observed, but no association 
between antibiotic susceptibility and the ability 
to survive low pH was made. Stopforth et	al. 
(2008) reported no difference in survival curves 
between 10 MDR and 10 antibiotic-susceptible 
isolates of Salmonella	spp. As yet, there is no 
conclusive evidence that acquisition of antibiotic 
resistance confers resistance to food processing 
stress in Salmonella	spp. Available data suggests 
that further experimentation is required.
VTEC – Pathogenic E. coli including
Introduction
Verocytotoxigenic Escherichia	coli	(VTEC), in 
particular O157, are an important cause of 
gastrointestial illness in the ROI (Epi-insight, 
2008). They have emerged as significant 
pathogens causing a range of severe (10% 
of patients developing Haemolytic ureamic 
syndrome (HUS)) and fatal illness. E.	coli O157:H7 
was the first E.	coli serotype to be associated with 
this distinctive illness. Additional verocytoxin-
producing serogroups, frequently reported in the 
ROI include, O26, O111, O103 and O145. Infection 
can be transmitted through food, contaminated 
water, the environment and by direct contact 
with animals or humans.
Description of species
E.	coli is arguably the best-known and most 
intensely investigated group of the bacteria 
found in humans and warm-blooded animals 
(Park et	al., 1999). It was first discovered by Dr. 
Theodore Eschrich in 1885 (Neill, 1994). E.	coli	are 
members of the Enterobacteriaceae	family and 
are characterised by being facultatively anaerobic 
Gram-negative rods, motile or non-motile, 
chemorganotrophic and having both a respiratory 
and a fermentative type of metabolism. 
They are oxidase-negative, Vogues-Proskauer 
negative, methyl red positive, catalase positive, 
usually citrate negative and have an optimal 
growth temperature of 37oC (Holt et	al., 1994). 
While E.	coli are considered to play a role in the 
maintenance of normal physiological function 
(Neill, 1994), there are pathogenic strains that 
cause diarrhoeal disease syndrome (Levine, 1987). 
Such strains are categorised into the following 
six groups based on virulence properties, 
mechanisms of pathogenicity, clinical syndromes 
and distinct O:H serogroups. Enteropathogenic 
(EPEC), Enterotoxigenic (ETEC), Enteroinvasive 
(EIEC), Diffuse adhering (DAEC), Enteroaggregative 
(EaggEC) and Enterohaemorrhagic (EHEC) are 
different types of E.	coli strains (Doyle et	al., 1997; 
Sussman, 1997). EHEC are a defined subset of 
VTEC, which are characterised by the presence of 
verotoxins (shiga toxins). The term EHEC refers 
to serotypes of E.	coli that cause a clinical illness, 
similar to that caused by E.	coli O157:H7, which 
produce one or more phage encoded shiga toxins, 
possess a 60-megadalton virulence plasmid and 
produce attaching-effacing lesions in an animal 
model (Griffin and Tauxe, 2001). 
VTEC in food on the island of Ireland
The presence of VTEC in food is of particular concern, 
as the minimum infectious dose is estimated to 
be as low as 10 viable cells. Two surveys carried out 
in the ROI in 2006 and 2007, found none of the 
retail products tested (238 and 573, respectively) to 
contain E.	coli O157 (see Table 8).
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Table 8 VTEC in food in the ROI 
Food type Tested for VTEC
2006
Positive 2006 Tested for VTEC
2007
Positive 2007
Fresh meat
Bovine 9 0 8 0
Pork 2 0 0 0
Poultry 2 0 0 0
Sheep 1 0 1 0
Unspecified meat 
and Other meat
24 0 0 0
Meat products
Bovine 28 0 49 0
Pork 65 0 14 0
Poultry 14 0 11 0
Sheep 2 0 0 0
Unspecified meat 
and Other meat
42 0 11 0
Other foods
Milk and milk 
products 
8 0 13 0
Fish and fishery 
Products
2 0 2 0
Fruit and 
vegetables
5 0 3 0
Juice 0 0 172 0
Soft Drinks 0 0 275 0
Other food 34 0 14 0
Total 238 0 573 0
(Source:	FSAI,	2009)	
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Other studies carried out on the ROI reported 
that, 2.4 per cent of beef trimmings, three per 
cent of beef carcass samples, one per cent of pre- 
and post-chill lamb carcass samples and 12 per 
cent of milk filters, were positive for E.	coli O157. 
Cagney et	al. (2004) reported that 2.7 per cent of 
supermarket mince-meat samples and 3.14 per 
cent of butcher shops mince-meat samples were 
positive for E.	coli O157 (Carney et	al., 2006).
Epidemiology of VTEC on the island of Ireland 
and in Europe 
In the ROI there were 115 confirmed and 521 
probable cases of VTEC notified in 2007 
(HPSC, 2007b). The crude incidence rate of 3.9 
cases/100,000 population represents a six per 
cent increase in the number of cases (n=158) 
reported in 2006. This is the highest annual total 
of VTEC infections ever reported in the ROI. Young 
children suffered the highest burden of VTEC 
with an age-specific rate of 17.5 cases/100,000 
population, and all five HUS cases occurred in 
children aged 1-7 years. Of the 115 confirmed 
cases, the most common serotype reported was 
O157 (n=94), followed by O26 (n=13). Two VTEC 
cases were mixed infections: one VTEC O157 and 
VTEC O103; the other VTEC O157 and VTEC O113. 
In NI, 47 cases of laboratory-confirmed VTEC were 
reported in 2006 with 17 cases in children aged 
0-4 (CDSCNI).
1 The 52 probable cases were associated with a single outbreak
The ROI, England, NI, Scotland and Wales have 
some of highest reported rates of infection in 
Europe (European Food Safety Authority, 2005); 
and in 2006, only Scotland (4.8 per 100,000) had 
a higher incidence than the ROI. In the EU, 2,905 
cases were reported in 2007 with an incidence of 
0.6 cases/100,000 population (EFSA, 2009). Data 
on serogroups was provided by 19 member states2, 
and of these over half (54.1%) were serogroup O157. 
A survey of Irish beef abattoirs carried out by 
Whyte (2009) E.coli – its prevalence and virulence 
in Irish beef, sheep and milk. Relay Final Report. 
Available at: http://www.relayresearch.ie/
Public/p_research_project_details.asp?project_
id=271 revealed that O157 is the most prevalent of 
five E.	coli serotypes capable of causing human 
illness. No E.	coli O111 was detected in the survey 
and despite the fact that O103, O145 and O26 were 
found only a few of these were pathogenic. E.	coli 
O103, O26 and to a lesser extent O157 are quite 
prevalent in Irish sheep populations. However, 
only a very small proportion of isolates possess 
the genes necessary to be highly pathogenic. 
The risk associated with raw milk appears low. 
This study highlights the need to establish the 
virulence in addition to the prevalence of E.	coli 
so that more meaningful assessments of risk to 
public health can be made. 
2  Austria, Belgium, Denmark, Estonia, Finland, France, Germany, 
Hungary, Ireland, Italy, Luxembourg, Malta, the Netherlands, 
Poland, Slovakia, Slovenia, Spain, Sweden and the United 
Kingdom
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Antimicrobial resistance in VTEC
To date, antibiotic resistance in VTEC has received 
little research attention. This is mainly because 
antibiotic therapy is not recommended in cases of 
VTEC-associated infection and VTEC-strains have 
been reported to be slower to acquire resistance 
than generic E.	coli strains (Mizan et	al., 2002; 
Sanchez et	al., 2002; Bettelheim et	al., 2003). 
However, more recently, multi-resistant strains 
of VTEC have been isolated from foods (Galland 
et	al., 2001; Schroeder et	al., 2002a; Schroeder et	
al., 2002b, Fitzgerald et	al., 2003; Schroeder et	
al., 2003), suggesting increasing proliferation of 
antibiotic resistance among VTEC. 
There is currently no surveillance data available 
on antibiotic resistance in VTEC on the island of 
Ireland, except for a few published studies in the 
scientific literature. Walsh et	al. (2006) compared 
the antibiotic resistance profiles of E.	coli O157:H7 
isolates (n = 257) recovered from bovine hides, 
mince-meat (ground beef) and human clinical 
samples in the ROI to those profiles of a range of 
Irish non-O157 E.	coli (O111 and O26) isolates (n=31) 
from a variety of clinical and veterinary sources 
(Walsh et	al., 2006). Four MDR E.	coli O157:H7 food 
isolates were identified, with resistance to 10 (one 
isolate), six (one isolate) and four (two isolates) 
antibiotics respectively. Another study by Murphy 
et	al. (2005) identified 16 antibiotic-susceptible 
strains of VTEC from Irish bovine milk used in the 
production of farmhouse cheese. One of these 
isolates was resistant to streptomycin. Murphy et	
al. (2007) also examined milk supplied (bovines, 
ovines and caprines) to the Irish farmhouse 
cheese sector and the manufacture of raw milk 
ice cream. All of the E.	coli O157:H7 isolates (n=19) 
were susceptible to the panel of 15 antimicrobials 
tested and among the O26 isolates (n=17), three 
were defined as MDR (ampicillin, tetracycline 
and streptomycin). The prevalence of MDR is 
considered to be low in VTEC isolates.
Even less information is available about antibiotic 
resistance in E.	coli O157:H7 in NI and the material 
that is available is usually subsumed within UK 
wide reports. Some information is available based 
on veterinary and human clinical cases which 
suggests that the incidence of antimicrobial 
resistant E.	coli O157:H7 remains very low in cattle 
and sheep isolates, low in pig isolates, and with 
the exception of tetracycline, very low in human 
clinical isolates (see Table 9). 
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Table 9 AMR (%) in UK veterinary and human VTEC isolates. (Adapted from AMR, 2004).
Antibiotic % of resistant isolates
Cattle Sheep Pig Human
Ampicillin 1 0 8 2
Cefoperazone (cephalosporin) 0 0 0 0
Ciprofloxacin 0
Sulphonamide/trimethoprim 0 0 8 20
Tetracycline 6 0 46 18
Although antimicrobial resistance in E.	coli 
O157:H7 is low in most cases, the situation is very 
different in non-VTEC E.	coli, where the incidence 
of resistance to antibiotics is high (>75%) or very 
high (i.e. >90%) in some animal species, posing 
the significant risk of transfer of (multiple) 
resistance to E.	coli O157:H7 by gene flow through 
the resistome.
Evidence of food processing impacts
Food processing impacts are of concern when 
dealing with low infectious dose pathogens, 
such as, E.	coli O157:H7, particularly with regard 
to the processing of ready-to-eat foods, such 
as, fermented meat. Only one study (Duffy et	
al., 2006) has compared antibiotic-resistant and 
antibiotic-sensitive VTEC under food-processing 
stress. In this study, the impact of laboratory-
acquired antibiotic resistance (to nalidixic acid 
and streptomycin) on the growth and survival 
of E.	coli O157:H7 and E.	coli O26 was examined. 
The presence of antibiotic resistance did not 
affect the growth kinetics (lag phases, growth 
rates) of the VTEC strains, over a 24-hour period 
at 37°C in laboratory media. The survival of the 
VTEC antibiotic-resistant strains in orange juice 
and yoghurt and their D-values at 55ºC were not 
significantly different to the parent antibiotic-
sensitive VTEC strains. However, another study 
by McGee (2003) reported that acid sensitivity 
occurred in one out of three antibiotic-resistant 
(nalidixic acid and streptomycin) E.	coli O157:H7 
isolates. Duffy et	al. (2006) also reported that the 
growth kinetics, lag phases and growth rates of 
an MDR E.	coli	O157:H7 (resistant to 10 antibiotics) 
over 24-hour at 37°C in laboratory media were 
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similar to all other strains tested (Duffy et	al., 
2006). However, when subjected to food stresses 
(acid and heat), this particular MDR E.	coli O157:H7 
isolate, was found to act very differently to the 
unstressed antibiotic sensitive and antibiotic-
resistant VTEC strains. All VTEC strains tested 
were found to survive for approximately 30 
days in orange juice at pH 4.4 and 25 days in 
yoghurt at pH 4.2. The exception was the MDR 
E.	coli O157:H7 isolate which was found to have 
died off significantly faster (P<0.05) in both 
media, than in the other strains tested. Thermal 
inactivation studies also showed the MDR strain 
to be significantly more heat sensitive (D
55
 value 
= 1.71 min) than all other VTEC strains examined in 
this study, or indeed in the wider literature (11.13 
to 139.2 min) (Juneja et	al., 1998; Clavero et	al., 
1998; Byrne et	al., 2002; Huang and Juneja, 2003). 
Thus, the acquisition of antibiotic resistance does 
change resistance to other stresses by increasing 
the AMR host sensitivity to environmental/food 
processing related stress. 
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Campylobacter
Antimicrobial resistance and virulence – 
Campylobacter
Campylobacter is the most commonly reported 
cause of bacterial foodborne infection on the 
island of Ireland. 
In the ROI in 2006, there were 1,815 notified cases 
of campylobacteriosis, giving a crude incidence 
rate of 42.8/100,000 population, a slight increase 
from 42.5 from the previous year (HPSC, 2006). 
The highest age-specific incidence rate was in 
0-4-year-old children at >120/100,000. Of the 38 
per cent of isolates with typing data, 91 per cent 
were C.	jejuni	and eight per cent were C.	coli. No 
data were available on antimicrobial resistance.
In NI in 2006, there were 937 cases of laboratory-
confirmed campylobacteriosis and of those 106 
were in 0-4-year-old children (CDSCNI).
There were 1,803 notified cases of 
Campylobacteriosis in 2005 – over five times the 
number of Salmonella	spp. cases. Of the infectious 
diseases caused by members of the Campylobacter 
genus, Campylobacter	gastroenteritis due to 
Campylobacter	jejuni and Campylobacter	coli	is the 
only form of disease that is of major public health 
importance (Oncul et	al., 2003). Campylobacter is 
a naturally transformable microorganism (Wang 
and Taylor, 1990) that is capable of acquiring a 
diverse array of Gram-positive (Werner et	al., 2001) 
and Gram-negative (Pinto-Alphandary et	al., 1990) 
AMR genes. Increasing antimicrobial resistance in 
both medicine and agriculture in Campylobacter 
is recognised by various national authorities, such 
as, the Food Safety Authority of Ireland, and global 
authorities such as the WHO as a major emerging 
public health concern (Moore et	al., 2006). 
Campylobacter may be transmitted to humans 
either directly or indirectly. Direct transmission 
can occur via contact with animals, carcasses 
or water which has been infected. Indirect 
transmission can occur through the ingestion 
of contaminated food or water. In the US, the 
highest risk factor for campylobateriosis is the 
consumption of commercially-prepared chicken 
(Rocourt et	al., 2003). 
In an all island study,	Campylobacter was isolated 
most frequently from retail poultry (chicken 
49.9%, turkey 37.5% and duck 45.8%) (Whyte et	
al., 2004). However, data from the EU in 2005 
showed that the incidence of Campylobacter spp. 
in fresh poultry meat at slaughter ranged very 
considerably from 4.6 per cent to 56.1 per cent. 
Similarly, at processing, the incidences ranged 
from 3.8 per cent to 51.9 per cent and at retail 
between 3.1 per cent and 66.4 per cent. Livestock 
production, in particular poultry production, has 
become very intensive across the island of Ireland 
during the last 20-30 years. Research has shown 
that by the third or fourth week of production, 
most poultry flocks are contaminated to some 
extent with Campylobacter	spp., resulting in the 
eventual spread of the organism to almost all 
members of the flock. In the above all Ireland 
study (Whyte et	al., 2004), Campylobacter was 
also isolated from beef (3.2%), pork (5.1%) and 
lamb (11.8%) and fresh mushrooms (0.9%). A 
number of more recent UK/NI/EU studies have 
reported Campylobacter	isolation rates of 63 per 
cent (DEFRA, 2006), 98.3% (EFSA, 2010) and 86.2 
per cent (Meldrum and Wilson, 2007) from poultry. 
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Recent isolation rates include raw meat (4.8%), 
pork (2%), lamb (8.5%) and raw milk (1.9%). Madden 
et	al. (2007) noted 24.8 per cent incidence in NI 
beef cattle faeces, suggesting a potential source 
for carcass contamination, although the incidence 
of Campylobacter on NI beef cattle carcasses is very 
low (Madden et	al., 2001). 
AMR is a common feature of Campylobacter	
isolated from food of animal and non-
animal origin. In a European study in 2006, 
Campylobacter isolates from poultry meat 
were found to have a high level of resistance to 
ciprofloxacin (30.6%) (Piddock, 2006). Resistance 
to this antibiotic was also high in isolates from 
fowl (Gallus gallus), pigs, cattle, at levels of 31.6 
per cent to 56.7 per cent. In addition, resistance 
to tetracycline was found to be very common 
(EFSA, 2006). In food animals, the prevalence of 
resistance to erythromycin is generally higher in 
C.	coli, in particular in C.	coli isolates from pigs, 
than in C.	jejuni (Engberg et	al., 2001). In Spain, 
it was found that the rates of erythromycin and 
quinolone resistance in C.	coli	from pigs were 81 
per cent and 100 per cent, respectively (Saenz et	
al., 2000). Antibiotics used in high concentrations 
in animal feed can be found in animal manure, 
which can end up as plant fertiliser (Kühn et	al., 
2003). In the US, poultry litter is spread on fields 
as a fertiliser which can be a source of MDR 
bacteria (Gangle, 2005). This has been shown 
in vitro by Batchelder and colleagues in 1981 
(Batchelder, 1982).
Information on the AMR profiles of Campylobacter 
spp isolated from animal/food sources in NI/
UK is generally regarded as weak, with the last 
UK survey of AMR in Campylobacter spp isolated 
from animals (carried out on pigs only) in 
2003. Although, there appears to be a trend of 
increasing resistance to quinolones (ciprofloxacin) 
and macrolides (erythromycin, Table 10), there 
is little updated data available to confirm this 
suggestion (Rao et	al., 2005). The majority of data 
originates from poultry isolates, and as such may 
not be representative of all food animal isolates. 
It has been reported that a high proportion 
of animal Campylobacter spp are resistant to 
ampicillin/tetracycline (>40%) and ciprofloxacin/
nalidixic acid (>20%). A recent report stated that 
22 per cent of chicken isolates have multiple 
AMR (resistant to three antibiotics or more), a 
significant advance from the report of Randall 
et	al. (2003) which suggested that 3.8 per cent of 
Campylobacter spp from combined human and 
animal origins were multi-resistant. It is not clear 
if this increased MAMR is matched in other food 
species, especially as wide variations have been 
reported in the AMR profiles of Campylobacter	
isolates from different types of retail meats. In 
general, Campylobacter spp isolated from pork 
and poultry have higher and broader resistance 
to antibiotics than lamb or beef. This may be 
attributable to the intensive farming methods 
used in pig and poultry rearing, where mass 
medication is relatively common and high 
stocking levels may facilitate dissemination of 
pathogens and AMR genes between animals 
(Turnidge, 2004; McGill et	al., 2006).
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A high proportion of animal Campylobacter spp are resistant to ampicillin/
tetracycline and ciprofloxacin/nalidixic acid.
On the island of Ireland, a high degree of 
similarity between the AMR/MAMR profiles of 
clinical and food Campylobacter spp isolates 
has been reported (McGill et	al., 2006), along 
with increased resistance to clinically relevant 
antibiotics, such as, ciprofloxacin, erythromycin 
and tetracycline among food isolates. In NI, 
Rao et	al. (2005) reported concurrent increases 
in erythromycin resistance in C.	jejuni isolates 
from humans and from poultry during the period 
1999-2003, although susceptibility to other 
antibiotics (penicillin, cefalexin, chloramphenicol, 
ciprofloxacin and tetracycline) remained static 
over this period. The above noted increase in 
erythromycin resistance is of clinical significance. 
The above data suggests that Campylobacter spp 
isolated from animal/food and those isolated 
from human campylobacteriosis may be linked 
via the food chain (Rao et	al., 2005, McGill et	al., 
2006), although GE et	al. (2002) noted significant 
delays between peaks of isolation. There is, 
however, a reported lack of temporal association 
between human infections and contamination in 
retail chicken products, particularly during peak 
seasons (Wilson, 2002). This may simply be due 
to the incubation period for campylobacteriosis 
infection of up to 10 days combined with the time 
taken for isolation, identification and reporting 
of the condition to the relevant public health 
authorities, which can be up to two weeks. The 
data made available in the report by Wilson 
(2002) indicates that a peak in Campylobacter spp. 
isolation from raw chicken is often followed 4-5 
weeks later by a peak in isolation from humans.
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Table 10 AMR profiles of Campylobacter spp in NI. 
% isolates resistant
Clinical 2001/2* 
(C.	jejuni)
Poultry meat 
2001/2* 
(C.	jejuni)
Other retail 
food products 
2001/2*  
(C.	jejuni)
Pig meat 
2002**  
(campy	spp)
Poultry meat 
2004** 
(C.	jejuni)
Amp 17 24 32 21 64
CHl 4.1 7.8 9 0 5
Cip 13 18 14 21 21
Ery 6.2 5.2 18 55 3
Nal 17 18 0 25 23
Tet 10 12 18 69 41
Data	from	
*	(McGill	et	al.	2006)	
**AMR	report	2004
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Fortunately, most cases of human Campylobacter	
enteritis do not require antimicrobial treatment, 
as the symptoms are usually clinically mild, and 
self-limiting in healthy adults (Casburn-Jones and 
Farthing, 2004). A survey conducted in the ROI in 
2003 found that only 7.4 per cent of those with acute 
gastroenteritis reported were taking antibiotics 
(Igoe et	al., 2003). However the symptoms of 
campylobacteriosis can vary from mild self-limiting 
enterocolitis lasting 24 hours to more severe 
illness including diarrhoea, abdominal cramps and 
vomiting which can last up to 10 days. For those 
immunosuppressed or with chronic intestinal 
disorders,	Campylobacter	infection can have more 
serious consequences and long-term antibiotic 
therapy may be necessary (McGill et	al., 2006). The 
use of Quinolones (ciprofloxacin) is considered to 
be the first choice for treatment as they are also 
considered useful for the prophylaxis of travellers’ 
diarrhoea (Ericsson, 2003; Piddock, 2006). This 
approach was adopted because the symptoms of 
Campylobacter	enteritis essentially mimic those of 
bacterial gastroenteritis caused by other enteric 
pathogens, such as, Salmonella	spp. and Shigella	spp. 
Furthermore, the susceptibility of these pathogens 
to fluoroquinolones, empirical treatment for severe 
gastroenteritis with these drugs was used before 
culture tests were confirmed (Alfredson and Korolik, 
2007). In 1991, Endtz et	al. reported quinolone 
resistant C.	jejuni and C.	coli isolated from humans 
were emerging in The Netherlands (Endtz et	al., 2002). 
Patients infected with fluoroquinolone resistant C.	
jejuni	tend to have longer duration of diarrhoea than 
patients with fluoroquinolone-sensitive isolates 
(Phillips et	al., 2004). Thus, macrolides (erythromycin) 
became the most commonly used agent for 
treatment of C.	enteritis	(Engberg et	al., 2001). 
It is interesting to note that the resistance of C.	jejuni	
and C.	coli isolates from humans in The Netherlands 
coincided with the introduction of fluoroquinolones 
in veterinary medicine in a number of countries 
(Aarestrup et	al., 1998; specifically in poultry (Endtz et	
al., 2002). Recognition of this relationship led to bans 
in the veterinary use of such products, for example, 
sarafloxacin was withdrawn from use during 2001 
(Gupta et	al., 2004), and in 2005, the Food and 
Drug Association banned the use of enrofloxacin, 
previously used in the treatment of colibacillosis in 
chickens and turkeys (Higgins et	al., 2007).
There are examples from many countries where 
fluoroquinolone-resistance rates are similar in 
isolates from poultry products and humans (Endtz et	
al., 1990; Wegener, 1999; Saenz et	al., 2000). In the UK, 
enrofloxacin was first licensed in late 1993. Previously, 
domestically-bred chickens were less frequently 
infected with quinolone-resistant Campylobacter	
than imported chicken products. Researchers found 
a correlation between the percentage of human 
isolates with antibiotics resistance and estimates 
of the amount of imported chicken consumed in 
the UK (Payne et	al. 2002). In recent data from Spain 
and Taiwan, rates of erythromycin resistance were 17 
per cent for both countries in C.	jejuni isolated from 
foods, whereas for C.	coli the rates were 50 per cent 
and 83 per cent, respectively (Li et	al., 1998; Saenz 
et	al., 2000). Macrolides, the current treatment of 
choice for campylobacteriosis, have been banned for 
use as a growth promoter in the EU since July 1999 
(Casewell et	al., 2003). However, the high incidence 
of resistance to erythromycin in C.	coli isolates from 
pigs has been related to extensive veterinary use of 
macrolides (Gibreel and Taylor, 2006; Kim et	al., 2006) 
during pig production.
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Evidence of food processing impacts
Since consumption of poultry is one of the major 
risk factors in acquiring campylobacteriosis 
it is worth considering the impact of poultry 
processing on antibiotic resistance of this 
pathogen. Slaughter and processing provide 
opportunities for reducing C.	jejuni	counts on 
food-animal carcasses. Bacterial counts on 
carcasses can increase during slaughter and 
processing steps. In one study, up to a 1,000-
fold increase in bacterial counts on carcasses 
was reported during transportation to slaughter 
(Stern et	al., 1995). Research studies carried out 
on chickens (Izat et	al., 1988) and turkeys (Acuff 
et	al., 1986) at slaughter, found that bacterial 
counts increased by approximately 10-to-100 
fold during defeathering with the highest level 
found after evisceration. However, bacterial 
counts on carcasses declined during other 
slaughter and processing steps. For instance, 
Oosterom et	al. (1983) reported that forced-air 
chilling of swine carcasses caused a 100-fold 
reduction in carcass contamination. In Texas, in 
turkey plants, scalding reduced carcass counts 
to near or below detectable levels (Acuff et	al., 
1986) and the addition of sodium chloride or 
trisodium phosphate to the chilled water in the 
presence of an electrical current reduced C.	jejuni 
contamination of chilled water by two log
10
 units 
(Li et	al., 1995). In a slaughter plant in England, the 
use of chlorinated sprays and the maintenance 
of clean working surfaces resulted in a 10-to-100 
fold decrease in carcass contamination (Mead et	
al., 1995). In another study, lactic acid spraying 
of swine carcasses reduced counts by at least 
50 per cent to undetectable levels (Epling et	al., 
1993). Furthermore, a radiation dose of 2.5 KGy 
reduced C.	jejuni	levels in retail poultry by 10 log10 
units (Patterson, 1995). Freezing or chilling of 
poultry meat has been shown to greatly reduce 
the number of live Campylobacter present on 
the product. In addition, it is thought that the 
aeration resulting from preparation of ground 
meat products helps reduce the number of 
viable cells of Campylobacter, as this organism is 
sensitive to high oxygen tension. 
During the slaughter of cattle and swine, fresh 
carcasses are cooled by forced air ventilation. This 
treatment both temporarily freezes and dries the 
surface, and this process has been documented to 
effectively reduce the number of Campylobacter	
cells on the surface of the carcass (Chang et	al., 
2003). Red or white meat undergoing any heat 
treatment or freezing during processing will 
harbour less Campylobacter than meat produced 
without such treatment. Furthermore, meat 
which is dried, cured, salted, smoked, irradiated 
or exposed to other preservation methods, 
will also harbour less Campylobacter	compared 
to the unpreserved product. The capacity of 
different treatment processes to affect the 
microbiological status of meat products is an 
area of intense interest. However, public demand 
for fresh poultry meat (e.g. cuts of breast meat), 
over whole frozen carcasses has contributed 
significantly to the decade-long increase in the 
incidence of human Campylobacter observed in 
many industrialised countries. 
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...when resistance emerges in Campylobacter in animals, resistant Campylobacter 
can be transmitted to humans.
There are no significant biological reasons why 
resistant Campylobacter	should not transmit 
equally well from animals to humans, as does 
sensitive Campylobacter. Hypothetically, there 
may be a small fitness loss when a strain of 
Campylobacter mutates and becomes resistant 
to quinolones, however, this loss of fitness may 
be compensated in successive generations. 
Thus, when resistance emerges in Campylobacter	
in animals, resistant Campylobacter can be 
transmitted to humans. In addition, results 
of a recent study have indicated that certain 
strains gain increased fitness when acquiring 
fluoroquinolone resistance mutations (Luo et	al., 
2005). This process is undesirable as it suggests 
that the acquisition of AMR can lead indirectly 
to the emergence of more widely generally, 
competitive AMR strains. Doyle and Erickson 
(2006) noted such effects as examples of the 
complex nature of antibiotic resistance and the 
large data gaps that exist in making informed 
scientific decisions on the use of antimicrobials in 
animals used as food.
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Methicillin-resistant Staphylococcus 
aureus (MRSA) 
Emerging/new pathogenic bacterial hazards
Staphylococcal food poisoning occurs after 
the ingestion of food contaminated with the 
staphylococcal enterotoxin(s) (A, B, C1, C2, C3, D, 
E, G, H, I, J, K, L, M, N and O) (Smyth et	al., 2006). 
It is mainly caused by human strains of S. aureus 
producing SE(A) and/or SE(D), with the majority 
of strains producing SE(A) alone. The amount 
of toxin necessary to cause illness depends 
on the susceptibility of the person. However, 
epidemiological studies have shown that only 
one μg of SE toxin can cause food poisoning. It 
should be noted that, to produce this amount 
of SE, an entertoxigenic strain needs to grow 
to levels of 105 to 106 cells per gram or ml. The 
onset of food poisoning symptoms usually occurs 
between one and seven hours after the ingestion 
of food containing SE. Symptoms include nausea, 
vomiting, abdominal cramps and diarrhoea. In 
severe cases, fainting may occur. Recovery is 
usually rapid, i.e. within two days.
Outbreaks and sporadic cases of staphylococcal 
food poisoning have been linked with foods 
such as, cheese, salami, bakery products, pasta, 
canned meat, canned fish and canned vegetable 
products. In relation to cheese, failure of the 
starter culture may provide an opportunity for S.	
aureus to grow and produce SE. Staphylococcal 
food-borne disease has been reported as 
the second most common cause of reported 
foodborne illness in the US (Halpin-Dohnalek 
and Marth, 1989). In the EU, 164 outbreaks 
were attributed to Staphylococcus spp. in 2005 
(European Food Safety Authority, 2006). This 
represented 3.1 per cent of all outbreaks reported. 
In 2004, only three cases of staphylococcal food 
poisoning were reported, in 2005 there were six 
cases and in both 2006 and 2007, no cases were 
reported in the ROI, however it is thought that 
this illness is under-report because the symptoms 
are generally not severe enough for the patient to 
visit their General Practitioners (Health Protection 
Surveillance Centre, 2004). Furthermore, because 
staphylococcal food poisoning is toxin mediated 
and generally self-limited, antibiotics are not used 
for the treatment of this illness (Gill and Hamer, 
2001).
MRSA is generally regarded as a health-care-
acquired, or increasingly, a community-acquired 
pathogen. Notably, MRSA was not reported as a 
cause of outbreaks of gastroenteritis until 2002 in 
the US. The reason is that many S.	aureus isolates 
obtained as part of outbreak investigations may 
not be tested for antibiotic susceptibility – and, 
therefore, Methicillin-Resistant Strains (MRS) 
may go unrecognised as the cause of foodborne 
outbreaks of acute gastroenteritis. MRSA are as 
likely to produce enterotoxins as are methicillin-
sensitive strains (Jones et	al., 2002). 
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...infection of humans by transmission through food products contaminated with 
animal MRSA may occur. 
In 2002, a reported outbreak in the US, found 
that MRSA contaminated food was the vehicle in 
a cluster of illnesses affecting low-risk persons 
within the community. This food was probably 
contaminated by an asymptomatic carrier whose 
only apparent exposures were intermittent 
visits to a nursing home (Jones et	al., 2002). 
This outbreak could be an example of second-
generation spread of a health-care-associated 
pathogen into the community. While antibiotic-
resistant strains are not expected to be clinically 
more virulent or challenging in the setting of 
acute outbreaks of gastroenteritis, MRSA may 
cause soft-tissue and other infections in the 
community that are difficult to treat. 
In the 1990’s an MRSA outbreak causing 21 
cases of septicaemia and five deaths occurred 
in the University Hospital Rotterdam, in The 
Netherlands. The initial reservoir for the outbreak 
strain was probably a dietary worker, who carried 
MRSA in his throat and prepared food for patients 
on the haematology unit. Transmission of MRSA 
by contaminated food had not been described 
before this outbreak (Kluytmans et	al., 1995). 
A study carried out in Korea from May 2001 to 
April 2003, found that, out of a total of 1,913 
specimens from cattle, pigs, and chickens, 
421 specimens contained	S.	aureus. Of the 
421 specimens, 15 were	mecA-positive MRSA 
isolates; twelve were obtained from dairy 
cows and three from chickens. The genomes 
of the six animal MRSA isolates, were very 
closely related to those of some human MRSA 
isolates and were a possible source of human 
infections caused by consuming contaminated 
food products made from these animals (Lee, 
2003). These results suggested that infection of 
humans by transmission through food products 
contaminated with animal MRSA may occur. 
More recently, a number of reports have reflected 
increasing concerns in this area (Kitai et	al., 2004; 
Lee et	al., 2003) especially considering ongoing 
increases in resistance to antibiotics which are 
typically part of MRSA’s resistant profile. Within 
the last year, MRSA has been reported in pigs, 
chickens and cattle in a number of European 
countries, but this organism is not yet included in 
UK/ROI food surveillance reports. 
While Staph	aureus food poisoning is toxin-
mediated and so the impact of MRSA food 
poisoning may not be more severe than 
susceptible SA, the use of antimicrobials in food 
animals poses a threat to public health through 
the introduction of new sources of MRSA into 
the human population. In The Netherlands, it 
has been demonstrated that pig farmers have a 
760-fold increase in carriage of MRSA over the 
general population, and there is evidence that the 
source of the MRSA is the pigs which have been 
exposed to antimicrobials. Hence, pig farmers 
are at a greater risk of exposing MRSA to their 
contacts, which in turn may affect the wider 
community. This source of MRSA threatens the 
highly successful efforts in The Netherlands to 
control MRSA in healthcare facilities.
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Clostridium difficile 
Clostridium	difficile	is not currently considered 
a foodborne pathogen and is usually found 
in the human large intestine (bowel). It is the 
most common cause of diarrhoea following 
antibiotic therapy and almost all patients who 
develop C.	difficile	diarrhoea are taking, or have 
recently been prescribed antibiotic therapy. A 
small proportion (less than one in 20) of the 
healthy adult population carry a small amount of 
C.	difficile, but it is kept in check by the normal 
bacterial population of the intestine. C.	difficile 
can also form spores which allow it to survive 
in the environment outside the body. These 
spores protect it against heat and chemical 
disinfectants. Most infections are reported from 
hospitals and nursing homes, but can also occur 
in the community. 
In most cases, C.	difficile	causes a relatively mild 
illness. However, infection may result in serious 
illness and even fatalities in patients of advanced 
age, and/or suffering from a serious underlying 
illness, or with conditions that compromise the 
immune system (e.g. cancer). In addition, patients 
who have recently had gastrointestinal surgery or 
those who have spent a long time in hospital or 
other healthcare setting are also at risk.
C.	difficile infection is generally not associated 
with individuals whose immune system is not 
already compromised. People can become 
infected if they touch items or surfaces that 
are contaminated with faeces and then touch 
their mouth or mucous membranes. Healthcare 
workers can spread the bacteria to other patients 
or contaminate surfaces through hand contact. 
The ability of C.	difficile	to form spores allows it 
to survive for long periods in the environment 
(including areas around the patient’s bed, the 
toilet areas, sluices, commodes, bed pan washers, 
on floors etc). Apart from the above principal 
symptom (diarrhoea), C.	difficile infection is also 
associated with fever, loss of appetite, nausea 
and abdominal pain/tenderness. Generally, 
C.	difficile takes advantage of the disruption 
of the normal, healthy intestinal bacteria by 
antimicrobial therapy. When C.	difficile is not 
challenged by the normal bacterial gut flora, it 
multiplies in the gut and produces toxins that 
damage the cells lining the intestine, resulting in 
violent and profuse diarrhoea. 
The presence of these organisms is normally 
detected by an Enzyme-linked Immunosorbant 
Assay (ELISA) assay binding C.	difficile toxin, 
a process that does not differentiate among 
the 100 strains of C.	difficile which have so far 
been identified. Recently, C.	difficile Type O27 
(first identified in the UK in 1999) has been 
demonstrated as the predominant strain in two 
outbreaks in the UK in 2004-2005. This strain 
was previously associated with a large severe 
outbreak in hospitals in Canada (Quebec) and 
North-Eastern USA commencing in 2000. Cases 
of infection with strain type O27 have been 
reported in other European countries, including 
the ROI (Epi-insight, 2006a). Early reports suggest 
that this strain is more virulent, since it produces 
a higher amount of toxin, than other ribotypes 
examined to-date. The production of high 
amounts of toxin in this ribotype, is the result of 
a deletion in the gene which normally restricts 
toxin production. C.	difficile Type O27 is believed 
to cause a greater proportion of severe disease, 
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...published data comparing human and animal isolates revealed the presence of 
C. difficile in food.
and to have a higher rate of mortality. This is not 
helped by the ease of transfer of C.	difficile	O27 
and infection between patients or its increasing 
resistance to fluoroquinolones. Resistance to 
fluoroquinolones and administration of these 
antibiotics has emerged as an important risk 
factor for C.	difficile associated diarrhoea in an 
epidemic in Quebec.
Recently published data comparing human 
and animal isolates revealed the presence of C.	
difficile in food. This finding strongly suggests 
that transmission from food animal reservoirs 
is a possible source for community-associated 
infections (Rupnik, 2007). C.	difficile-associated 
disease or asymptomatic carriage has been 
described in animal species (Songer and 
Anderson, 2006), but the C.	difficile types in the 
human and the animal populations have not 
been compared in detail. If animals are indeed 
a potential source of C.	difficile infection, food 
could be one of the transmission routes from 
animals to humans. Approximately 20 per cent 
of retail ground meat samples or other retail 
meat products have been shown to contain C.	
difficile (Rodriguez-Palacios et	al., 2007) and at 
least some of the ribotypes found in meat (O77, 
O14, M26, M31) have been recovered from dogs, 
calves and humans. Type M26 is identical in a 
number of molecular characteristics (toxinotype 
III, 18-bp deletion in	tcdC, presence of binary toxin) 
to type O27, and was also found to be resistant 
to levofloxacin and clindamycin. However, the 
ribotyping and pulsed-field gel electrophoresis 
profiles of Type M23 are only 80 per cent similar 
to O27 strains from humans. C.	difficile could 
contaminate meat during processing, but another 
possibility is that spores are already present in 
the muscle tissue. The latter possibility has been 
described for other clostridial species in horses, 
but not for C.	difficile (Vengust et	al., 2003). 
Whether antibiotic resistant strains of C.	difficile	
are affected differently by processing compared 
to non-antibiotic-resistant strains remains to 
be determined, but further evaluation is still 
required on the exact role of food as a route of 
transmission of this micro-organism.
A marked increase in Clostridium	difficile 
Associated Disease (CDAD) has been reported 
across Europe and North America over the past 
decade or so, and for the EU alone, the potential 
cost of CDAD has been estimated as three billion 
euro annually (Kuijper et	al., 2006). Kuijper et	al. 
(2006) noted that CDAD is an increasing threat to 
human health, with multiple issues of concern, 
including an increase in the elderly and vulnerable 
population in Europe, and an increase in reports 
of resistant and more virulent strains of C.	difficile 
and C.	difficile strains that are more difficult 
eliminate from the environment due to resistance 
to many cleaning agents (Kuijper et	al., 2006). The 
control of C.	difficile is an important challenge in 
human healthcare and it is essential that no new 
source from animal reservoirs is allowed to occur.
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Commensal non-pathogenic 
bacterial hazards
Commensals may play a role in the spread of 
antibiotic resistance, through the dissemination 
of resistance genes to susceptible bacteria. In 
humans and animals this is most likely to occur in 
the intestinal tract, where the ability of bacteria 
to colonize, transfer and accept resistance 
determinants remains important. A knowledge gap 
exists on the prevalence of antibiotic resistance 
genes in the animal and human intestines. The two 
most studied bacteria of the gastrointestinal tract 
(Enterococci	and E.	coli) make up only one per cent 
of the total intestinal microflora. The majority of 
intestinal bacteria cannot be cultivated, and much 
of the limited knowledge that exists, is about 
the minority, cultivatable (potentially atypical) 
populations (EFSA, 2008). 
The application of culture-free and genomically-
based forms of detection and differentiation 
to these complex populations is likely to make 
considerable contributions to our understanding of 
the interactions of such commensals with enteric 
pathogens. This in turn should clarify the relative 
significance of the presence of antibiotic genes in 
commensals in the acquisition and dissemination 
of these genes in zoonotic/enteric pathogens. 
However, it is also important to note that many 
of the commensals which are amenable to 
current analytical methods have already been 
shown to carry qualitatively and quantitatively 
significant complements of antibiotic-resistant 
genes. For example, in recent times there have 
been significant increases in the percentage of 
vancomycin-resistant Enterococcus	faecium (37.1%) 
and ciprofloxacin-resistant E.	coli in the ROI, while 
the proportion of MRSA has remained stable, 
albeit high, at approximately 42 per cent for the 
past four years (Epi-Insight, 2006b). 
Enterococcus spp
Enterococci	are Gram positive, facultative 
bacteria with low intrinsic virulence. They are 
natural inhabitants of humans and animals and 
are occasional opportunistic pathogens of the 
urinary tract, bloodstream, intra-abdominal 
and pelvic regions, surgical sites and the central 
nervous system (Murray and Weinstock, 1999). 
Enterococcus	faecalis are responsible for 80-
90 per cent of human enterococcal infections 
(Jones et	al., 2004) and Enterococcus	faecium	is 
generally responsible for the remainder. Both 
species are reported to be intrinsically resistant 
to cephalosporins, low concentrations of 
aminoglycosides, clindamycin, fluoroquinolones 
and trimethoprim-sulfamethoxazole. In 
addition, many strains harbour transmissible 
genetic elements for acquired resistance to 
tetracycline, erythromycin and chloramphenicol 
and most importantly glycopeptide antibiotics 
(vancomycin, teicoplanin). The mechanism 
of vancomycin and teicoplanin resistance 
in Enterococci	is based on the presence of a 
particular type of peptidoglycan precursor 
terminating in D-Ala-D-lactate instead of D-Ala-
D-Ala, the normal binding site of glycopeptides 
(Bugg et	al., 1991). The key enzymes involved are 
specific ligases VanA or the less common ligase 
VanB. The gene cluster coding for resistance 
contains four or five other genes in addition to 
the ligase. The additional genes which contribute 
to the phenotype include; vanR,	vanS,	vanH,	vanX	
or	vanZ. This gene cluster is often associated 
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In 1996, there were 265 reports of	E.	faeclum bacteraemia in the ROI, of which 37.1 
per cent were vancomycin resistant.
with a transposon (Tn1546), highlighting the 
potential for resistance transfer (Arthur and 
Courvalin, 1993). Other clinically important 
resistance types include vanC,	vanD and	vanE	type 
ligases (Cetinkaya et	al., 2000). During the past 
two decades, the incidence of hospital-acquired 
infections has risen and these are increasingly 
associated with MDR (Linden et	al., 2007). While 
vancomycin resistance may compromise the 
treatment of nosocomial infections, there is 
concern for the eventual transfer of vancomycin 
resistance to MRSA and the serious consequences 
that this might entail. 
Antimicrobial resistance in  
Enterococcus faecalis
In 1996, there were 294 reports of E.	faecalis	
bacteraemia in the ROI, of which 3.7 per cent 
were vancomycin–resistant isolates. While this 
percentage may seem low, the ROI has one of the 
highest proportions of vancomycin–resistant E.	
faecalis in Europe (Epi-Insight, 2007b)
Antimicrobial resistance in  
Enterococcus faecium
In 1996, there were also 265 reports of E.	
faecium bacteraemia, of which 37.1 per cent 
were vancomycin resistant, the proportion of 
vancomycin resistant isolates had increased by 
6.4 per cent per year. Of the 265 strains isolated, 
25.6 per cent were found to be MDR, showing 
an increase of six per cent per year, reported 
between 1991 and 1996 (Epi-insight, 2007b). 
Foods associated with Enterococci
Enterococci are widely distributed in the 
environment, human and animal gastrointestinal 
tracts, and are frequently isolated from raw 
milk, meat, vegetables, or any food that comes 
in contact with soil or surface water. However, 
their presence in food products is not always 
correlated with faecal contamination, making 
them inefficient hygiene indicators in food 
processing plants (Birollo et	al., 2001). The 
ability of this species to survive pasteurisation 
temperatures and grow under a wide range of 
adverse conditions (high and low temperatures, 
pH and salinity) enables them to persist in 
processed food products. Enterococci are also 
associated with fermented foods, (such as, 
cheeses and meats) and are widely used as starter 
cultures in the food industry. 
Evidence of food processing impacts 
There is currently no literature available on any 
differential effects of food processing stresses 
on antibiotic-susceptible and antibiotic-resistant 
Enterococci. However, there is evidence that 
conditions within the food-chain may assist in 
the dissemination of resistant genes, for example, 
there are reports that the vanA gene has been 
transferred in	vivo from chicken isolates to human 
strains (Lester et	al., 2006). This worrying report 
highlights the real potential for the transfer of 
antibiotic resistance from animal/food isolates 
to human isolates within the food chain, and 
underlines the need for further investigation 
of the factors controlling or stimulating such 
transfers, especially when one considers the 
types and incidences of AMR involved.
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Non-pathogenic E. coli 
Description of Species 
Previously described see pathogenic E.	coli 
including VTEC (Section 4).
Antimicrobial resistance in E.	coli
In the ROI in 2006, 21.5 per cent of E.	coli were 
resistant to drug ciprofloxacin, a fluroquinolone 
drug. This has increased significantly from 5.4 
per cent in 2002, at a rate of approximately four 
per cent increase per year. In wider terms, E.	coli 
have also been found to be resistant to ampicillin 
(70.7%), third generation cephalosporin’s (4.2%), 
aminogycosides (7.7%) and Extended Spectrum 
ß-Lactamases (ESBL) (20.8%). The above levels of 
fluoroquinolone-resistance incidence are higher 
than in the rest of Europe, while the levels of 
cephalosporin and aminoglycoside resistance are 
lower. On a positive note, no significant increase 
in ESBL-producing bacteria has been observed in 
the ROI in recent years. Overall, nine per cent of 
E.	coli tested in 2006 were reported to be MDR 
resistant. This is in contrast to 2.4 per cent in 
2002, an increase of approximately 1.7 per cent per 
year (Epi-Insight, 2007b).
Food associated with E.	coli
Food products particularly associated with 
outbreaks of E.	coli food poisoning include; raw 
ground meat, fermented meat, raw unwashed 
fruits and vegetables (in particular spinach and 
sprouts), raw milk, unpasteurised juice,or foods 
contaminated by infected food workers via 
faecal-oral route. (For further information see 
verocytotoxigenic E.	coli).
Evidence of food processing impacts 
Evidence of the impact of food processing on 
antibiotic resistant E.	coli has been previously 
discussed in the section on non-pathogenic VTEC. 
No information is available on the impact of food 
processing stresses on ABR in commensal E.	coli.
Probiotics added to food 
Bacteria have been added to foods for a long time, 
and their application in the production, flavour and 
texture modification of a diverse range of food 
items remains a very important activity of the food 
industry. For example, bacterially-cultured dairy 
products remain the driving force in the growth of 
dairy food consumption with generated retail sales 
close to $4.8 million (a3.8 million3; £3.4 million) 
in 2005 (Cogan et	al., 2007). Lactic acid bacteria 
(LAB) play a vital role in the manufacturing, flavour, 
texture and the development of fermented dairy 
foods. These include lactobacilli, lactococci, 
streptococci, enterococci, pediococci and 
leuconostocs. More recently the health benefits of 
these bacteria have been studied, with LAB such 
as, lactobacilli, enterococci or Bifidobacteria	spp. 
being used in the production of probiotic products. 
Most food-associated LAB have ‘Generally 
Regarded As Safe’ (GRAS) status, since there 
have been no reports of clinical cases associated 
3  Currency exchange rate = $1USD is equivalent 
to 0.7920 euro and 0.7016 pound sterling 
(accessed 17th February, 2009)
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In the ROI in 2006, 21.5 per cent of E.	coli were resistant to drug ciprofloxacin...
with industrial starter strains. A few clinical 
cases associated with probiotic Lactobacillus	
rhamnosus	have been reported (Rautio et	al., 
1999; de Groote et	al., 2005), however these 
incidences are quite isolated given the extensive 
use of LAB. This suggests that the chances of 
bacterial infection associated with LAB are 
remote, and that the presence of antibiotic-
resistance genes in LAB does not present any 
significant, direct challenges to clinical medicine. 
However, there are now increasing concerns 
that antibiotic resistant genes present in non-
pathogenic bacteria (like LAB) can be transferred 
to pathogenic strains. The fact is that many 
fermented dairy products and meats that are not 
heat-treated before consumption may provide 
a vehicle for antibiotic-resistant bacteria with 
a direct link between the animal indigenous 
microflora and the human gastrointestinal tract 
(Mathur and Singh, 2005).
Few comprehensive studies exist on antibiotic 
resistance in LAB of food origin, in particular 
lactococci and lactobacilli. Research has 
mainly focused on the opportunistic pathogen 
Enterococci. Since Enterococci	have been previously 
discussed in this report, current antibiotic-
resistant genes are listed for non-enterococcal 
LAB and	Bifidobacteria spp. (Table 11).
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Table 11 AMR genes in non-enterococcal LAB and Bifidobacteria spp. (Modified from Ammor et al., 2007)
Species/Strain name Resistance Gene(s) Strain Origin
Bifidobacterium	longum tet(W) Animal, Human
tet(M) Human
Bifidobacterium	spp. tet(W) Animal, Human, Probiotics
Lactobacillus	acidophilus aaa(6’)Ie-aph(2”)Ia Animal
tet(M), erm(B) Dairy produce, Human
Lactobacillus	alimentarius tet(M) Fermented Dry sausage
Lactobacillus	animalis erm(B) Animal
Lactobacillus	casei tet(M), erm(B) Dairy produce, Human
Lactobacillus	crispatus erm(B) Animal, Human
tet(M) Human
Lactobacillus	curvatus tet(M) Fermented dry sausage
Lactobacillus	fermentarium tet(M), erm(B) Human
erm(LF), vat(E-1), tet(M) Dairy produce
erm(B) Animal
Lactobacillus	gasseri tet(M), erm(B) Dairy produce, Human
Lactobacillus	johnsonnii erm(B) Animal, Human
tet(M) Human
Lactobacillus	plantarum tet(M), erm(B) Dairy produce, Fermented dry 
sausage, Human
tet(S) Human
cat-TC Pork
Lactobacillus	reuteri tet(W), Inu(A) Human
erm(B), erm(T), cat-TC Animal
Lactobacillus	rhamnosus tet(M), erm(B) Human
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A number of AMR genes are found in non-enterococcal LAB and Bifidobacteria spp.
Lactobacillus	sakei tet(M) Fermented dry sausage
Lactobacillus	salivarius aaa(6’)-aph(2”), erm(B) Animal
Lactobacillus	spp. erm(T) Animal
tet(M), tet(O), tet(T) Human
tet(K), tet(S), tet(W), tet(36) Human
Lactobacillus	lactis tet(M), tet(S), mdt(A), cat, str Dairy produce
erm(T) Animal
Leuconostoc	citreum tet(S) Sausage Process line
Pediococcus	acidilactici erm(B) Animal, Dairy produce
aaa(6’)-aph(2”) Animal
Resistance genes: aac, aminoglycoside 
acetyltransferase; ant, aminoglycoside 
adenylyltransferase; aph, aminoglycoside 
phosphotransferases; cat chloramphenicol 
acetyltransferase; erm, erythromycin resistant 
gene; Inu, lincosamide resistance gene; mdt, 
multiple drug transporter; str, streptomycin 
resistant gene; tet, tetracycline resistant gene; 
vat, streptogramin A acetyltransferase.
Conjugative plasmids for lactose utilization 
(and/ or proteinase activity) were first reported 
in Lactococcus	lactis (Fitzgerald and Gasson, 
1988). Since then, many R-plasmids have been 
reported in Lactobacilli (reuteri,	fermentum,	
acidophilus,	plantarum) and Lactococcus (lactis) 
(Lin et	al., 1996; Fons et	al., 1997; Vescovo et	al., 
1982, Danielsen, 2002), but the rates of plasmid 
transfer from these bacteria has been reported 
to be low (Mathur and Singh, 2005). Two in-vitro 
studies (Morelli et	al., 1988; Igimi et	al., 1996) 
have examined conjugative transfer in the gut 
microflora. A broad host range conjugative 
plasmid (pAMß1), was transferred into L.	reuteri	
and L.	lactis. These strains were then administered 
orally or by gastric tube to mice and the faecal 
contents were analysed to show plasmid transfer 
into E.	faecalis. Enterococci	spp. are known to be 
receptive for conjugation (Clewell and Weaver, 
1989), but are also good at transferring antibiotic-
resistant plasmids into Gram-negative (Courvalin, 
1994) and Gram-positive bacteria (Perreten et	al., 
1997), at rates of log
10
 10-4 to 10-9 transconjugants 
per recipient, in LAB (Mathur and Singh, 2005). 
While much attention has focused on antibiotic 
resistance in enterocococci, more antibiotic 
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resistance transfer studies are required in non-
enterococcal LAB, to examine their potential role 
in the dissemination of antibiotic resistant genes.
There are no reports linking conjugative 
transposons and antibiotic resistance in LAB, 
with the exception of those found in E.	faecalis, 
(Tn916, Tn918, Tn920, Tn925, and Tn2702), E.	
faecium	(Tn5233), S.	pyogenes (Tn3701), and S.	
agalactiae	(Tn93951). These transposons have 
been reported to carry resistance to tetracycline, 
erythromycin, chloramphenicol and kanamycin. 
Transposons also have the ability to mobilise 
unrelated plasmids or other chromosomal genes 
containing antibiotic resistance or virulence 
genes. The transfer (in-vitro) of tetracycline 
resistance (tet(M)) from E.	faecalis to other LAB via 
a transposon has been reported to be between 
log10 10-6 to 10-9 transconjugants per recipient. 
Impact of antimicrobial resistance in LAB
The widespread use of LAB and bifidobacteria 
in fermented food and dairy products has a 
safe history. While MDR is not common in 
these isolates, LAB like all other bacteria, are 
prone to gene exchange (Mathur and Singh. 
2005). For these reasons, AMR will need to be 
monitored in these isolates, so that no starter or 
probiotic culture containing antibiotic-resistant 
determinants are used in food production.
Genetically Modified Organisms 
(GMOs)
Under EU law a genetically modified organism 
(GMO) is defined as an organism whose genetic 
material has been altered in such a way that does 
not occur naturally by mating and/or natural 
recombination (Commission for the European 
Communities, 2000). A number of concerns have 
been raised about the use of this technology 
including food safety issues, potential damage 
to the environment, disruption of ecosystems, 
as well as ethical and moral objections. In 
particular, questions have been raised about 
the relationship between antibiotic resistance 
and this technology. By linking an antibiotic 
resistant ‘marker gene’ to the ‘gene of interest’, 
only cells that incorporate the new genes into the 
bacterial cell will proliferate in the presence of an 
antibiotic, while cells which have not accepted 
the new genes fail to grow. Such a linkage has 
specific operational advantages in the detection, 
purification and cultivation of the “gene of 
interest”, but may have negative effects in terms 
of the transfer and dissemination of AMR.
There are many ways in which GMOs can 
be produced, e.g., chromosomal alterations 
(Johansen, 1999), recombinant DNA methods 
(Curic et	al., 1999), or introduction of additional 
genes (Kondo and Johansen, 2002). Traditional 
cloning vectors normally contain antibiotic-
resistance determinants as selectable markers, 
but these are considered unacceptable for 
food use. Initially food grade selection was 
based on nisin resistance (von Wright et	al., 
1990), however intrinsic resistance to nisin in 
L.	lactis prevented further development of this 
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marker. An alternative system is carried out by 
deleting a ‘marker gene’ present in the bacteria 
and reintroducing the same ‘marker gene’ on 
a plasmid (McCormick et	al., 1995). However, 
this system has only been tested in laboratory 
strains. Another system which has been tested 
in industrial strains is the nonsense suppressor 
tRNA located on a plasmid which suppresses a 
nonsense mutation in the	pyrF gene on the host 
chromosome. The disadvantage is that specific 
strains must be developed to act as a host for 
the food-grade vector. Strains over expressing 
aminopeptidases have been used successfully in 
small-scale cheese production (Dickley et	al., 1995; 
Guldfeldt et	al., 2001). 
Impact of GMO’s in antimicrobial resistance
The risk of the transfer of AMR genes to gut 
micro-organisms is considered low. However, 
the use of AMR markers is being phased out and 
replaced with other markers, such as those for 
herbicide resistance. Currently, only four types 
of GM crops may be found in food products on 
the Irish market including soya bean, rape seed, 
maize, and cotton seed), making up 0.5 per 
cent of the total ingredient/food (FSAI, 2004). 
All four crops are resistant to herbicides, with 
the latter two resistant to pest attack. This is 
in agreement with the ‘Guidance document 
of the Scientific panel of Genetically Modified 
Organisms for the Risk Assessment of Genetically 
Modified Microorganisms and their Derived 
Products Intended for Food and Feed Use’ (EFSA, 
2006b), which recommends the use of alternative 
technologies that do not rely on antibiotic 
resistance markers. This guidance document 
also considers information about location and 
potential for transfer of each gene sequence. The 
phasing out of antibiotic-resistant marker genes 
will eliminate the potential for dissemination 
of resistance genes via GMO’s in the future. On 
the request of the European Commission, the 
European Food Safety Authority (EFSA) issued 
an updated opinion in June 2009 on ‘marker’ 
genes, in particular antibiotic resistance marker 
genes, present in GMO’s authorised in the EU. The 
panels concluded that, according to information 
currently available, adverse effects on human 
health and the environment resulting from the 
transfer of the two AMR marker genes, nptil and 
aadA, from GM plants to bacteria, associated with 
use of GM plants, are unlikely. 
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...little information is available on the transfer of AMRt genes in food matrices. 
Evidence of increased resistance to 
food preservation stresses
Conjugation
Horizontal transfer of genes between different 
species of bacteria (Neuwirth et	al., 2001, Winokur 
et	al., 2001) is an evolutionary phenomenon 
whose extent and significance has been subject 
to intense debate. The maintenance and stability 
of transferred genes suggests that they confer a 
selective advantage on the recipient organism. 
In most cases the nature of this advantage is 
not understood, but the biological and clinical 
significance of the transfer of AMR genes 
remains clear (Koonin et	al., 2002). Gene transfer 
experiments have been carried out successfully in 
several backgrounds including the intestines of 
various animals (Bourgeois-Nicolaos et	al., 2006), 
in the human colon (Shoemaker et	al., 2001) and 
in cultured human cells (Ferguson et	al., 2002). 
Other environments investigated in a similar 
manner included bovine rumen fluid (Mizan et	al., 
2002), sewage (Ohlsen et	al., 2003), surface water 
(Arvanitidou et	al., 1998) and calf faeces (Yates 
et	al., 2004). However, very little information is 
available on the transfer of AMRt genes in food 
matrices. While several studies have successfully 
demonstrated laboratory-based gene transfer 
by conjugation with food-borne strains in broth 
(liquid mating) (Allen and Poppe 2002; Chen et	al., 
2004; Wilks et	al., 2005) or by filter (solid surface) 
mating (Pourshaban et	al., 2002; Gevers et	al., 
2003), data describing the in-situ food matrix is 
limited (Cocconelli et	al., 2003). 
Walsh et	al. (2008) reported the transfer of an 
ampicillin-resistance marker via an R-plasmid 
from S. Typhimurium DT104 to a susceptible 
recipient E.	coli K12 in broth, milk and ground 
meat, at 25°C and 37 C˚ within 24-hour. A higher 
rate of transfer (10-2 cfu g-1 transconjugants per 
recipient) was reported in ground meat at 48 
hour. Similarly, Van der Auwera et	al. (2007) 
reported plasmid transfer (at 10-1 cfu ml/g -1 
transconjugants per recipient) for Bacillus	
thuringiensis in broth, milk and milk pudding. 
Cocconelli et	al. (2003), reported the transfer 
of vancomycin resistance via a conjugative 
R-plasmid in enterococcal strains during cheese 
and sausage fermentation. These authors 
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reported a 2-3 log (cfu g-1) increase in the transfer 
rate of plasmids in meat, and suggested that 
factors including plasma in the meat matrix could 
be important. These differences may depend on 
the nature of the food matrix as human plasma, 
since plasma is reported to have a positive effect 
on plasmid transfer (Hirt et	al., 2002). 
Another recent study by McMahon et	al. (2007) 
showed increased rates (P<0.05) of resistance 
transfer under typical food processing stresses 
(high/low temperature, osmotic and pH stress), 
compared to controlled conditions (McMahon 
et	al., 2007). These effects could be related to 
increased activity or efficiency or one or more 
of the steps involved in resistance transfer, 
e.g. improved plasmid release/transfer or more 
efficient plasmid capture under stress. Selective 
pressures conferred by bacteriostatic, rather 
then bactericidal food preservation protocols, 
may be a driving force in the emergence of 
antibiotic resistance among zoonotic pathogens. 
However, to-date a knowledge gap exists on the 
relationship between food preservation stress 
and the transfer of antibiotic-resistance genes. 
For this reason, the mechanisms, incidence, 
and the epidemiological significance of stress-
enhanced transfer of AMR remain unknown. 
Transformation 
Several bacterial species are naturally 
transformable, under a range of circumstances, 
including specific chemical or physical conditions 
(Davison et	al., 1999). Food processing can 
compromise the bacterial cell-membrane 
integrity enhancing the uptake of resistance 
genes on acquired extra-chromosomal DNA (Neu 
et	al., 1996). Transformation is enhanced by close 
contact with high concentrations of DNA and 
environments rich in nutrients, such as, biofilms 
(Baur et	al., 1996), frequent circumstances 
encountered in many parts of the food industry 
environment (Arnold and Silvers, 2000). 
Increased natural competence of bacterial cells 
can be induced by salts, temperature shifts and 
electro-shocks (Davis et	al., 1999; Cérémonie et	
al. 2004; 2006), although DNA released from 
lysed bacterial cells is vulnerable to physical 
degradation during processing. For example, 
heat, shearing force, chemical degradation 
and natural DNA-ases present in food, such as, 
arginine, polyamines and biogenic amines (van 
den Eede et	al. 2004; Weiss et	al. 2007). Thus, 
food preservation technologies may injure cells 
enhancing DNA release, but also modify such 
DNA, allowing competent bacteria to acquire new 
or modified characteristics, such as antimicrobial 
resistance (IFT, 2006).
The development of competency and natural 
transformation has been demonstrated in Bacillus	
subtilis in milk (Zenz et	al., 1998; Kharazmi et	
al., 2002). However the extent to which food 
processing contributes to the occurrence of 
transformation in food is unknown.
Transduction
While there are many reports of transduction 
of antibiotic-resistance genes within laboratory 
studies, there is no information available on 
transduction in the environment or in food. Its 
importance as a mechanism for gene transfer is 
questionable because of the high specificity of 
the phages required (Ammor et	al., 2007). 
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Increased restriction and/or prohibition of the use 
of antibiotics as growth promoters, or hygiene 
aids, has necessitated an increase in the use of 
(alternative) biosecurity measures. These include the 
application of biocides to reduce microbial numbers 
which inevitably contaminate food processing 
equipment, surfaces and environments (Karatzas 
et	al., 2007). These biocides differ from antibiotics 
in that they are usually broad-spectrum chemical 
agents, inhibiting or killing a wide range of micro-
organisms by non-specific means (White et	al., 
2003). They are differentiated into disinfectants and 
sanitizers based on testing, claims and directions for 
use. Thus, a disinfectant must completely eliminate 
all the organisms listed on its label (including fungi 
and viruses), whereas a sanitizer need not eliminate 
all target organisms to be effective, nor are fungi 
and viruses ever included on a sanitizing claim. 
Although biocides and antibiotics inactivate 
bacteria in very different ways, there is 
increasing concern that biocides may directly 
or indirectly stimulate the development and 
emergence of antimicrobial resistance by 
inducing sublethal stress. Thus their increasing 
application in food processing and domestic food 
preparation environments may be stimulating the 
development and dissemination of antimicrobial 
resistance in the human food chain. Biocide use 
included surface treatment with; alcohol, oxidizing 
compounds, hypochlorite, QACs, acid anionics, 
acidified sodium chlorite and chloride dioxide, and 
in hand care products e.g. triclosan, para-chloro-
meta-xylenol and chlorhexidine (IFT, 2006). 
Biocides
The efficacy of biocides and the types of organisms 
that they inhibit vary considerably and are 
dependent on the compositional concentrations and 
synergism among these components (Russell, 2000). 
In contrast to antibiotics, biocides demonstrate a 
non-specific killing by coagulation of the cytosol 
and by damaging the cytoplasmic membrane. 
This is in marked contrast with the highly specific 
effects of antbiotics, many of which target very 
specific mechanisms within target cells.
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Biocide resistance
Resistance to biocides (disinfectants) is considered 
to be unlikely to occur, as most disinfectants are 
complexes of antimicrobial agents that inactivate 
multiple cellular targets (McDonnell and Russell, 
1999; Russell, 2003). These compounds can also 
be applied at concentrations many times higher 
than the minimum inhibitory concentration (MIC). 
For this reason, decreased susceptibility does not 
always confer decreased bactericidal activity (Jones, 
1999). Factors reducing the effectiveness of biocides 
include the presence of organic material and biofilm 
growth (Gilbert and McBain, 2001). Inadequate 
disinfection procedures in livestock production 
facilities and food processing plants and 
household environments may contribute to the 
selection of biocide resistant isolates as a result of 
exposure to sublethal biocide concentrations. 
Reports of biocide resistance
Staphylococci showing decreased susceptibility 
to QACs have been isolated from food processing 
plants (Sundheim et	al., 1998; Heir et	al., 2004). 
Langsrud and Sundheim reported that more than 
30 per cent of Pseudomonas spp. isolated from 
poultry carcasses can grow in the presence of 
benzalklonium chloride at concentrations used in 
the poultry plant (Langsrud and Sundheim, 2004). 
Resistance to QACs has been demonstrated in 
Listeria spp. isolated from poultry products, red 
meat and cheese (Lemaitre et	al., 1998). In contrast, 
a recent report showed that biocide resistance 
was not a contributing factor to the persistence of 
strains of L.	monocytogenes and E.	coli in the food 
products and the environment of five chilled food 
production facilities (Hojah, 2002), suggesting that 
biocide resistance is only one of the factors involved 
in pathogen selection/survival. Little is known about 
the effects of low concentrations of biocides on 
bacterial biofilms. It may be of potential significance 
to the food industry that in-vitro studies found 
incomplete elimination of biofilm by biocides. This, 
in-turn, may lead to increased biocide resistance, 
due to the selection of highly resistant clones 
(McBain et	al., 2003).
Biocides commonly used in the food industry 
and in domestic settings
Biocides commonly used in the food industry 
are listed in Table 12. Similar biocides are used in 
a domestic environment, in particular triclosan, 
QAC’s, chlorhexidine (Braoudaki and Hilton, (2004a), 
hypochlorite (bleach) and chlorine (sometimes in 
combination with zinc) (IFT, 2006).
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selection of biocide resistant isolates as a result of exposure to sublethal  
biocide concentrations. 
Table 12 Biocides commonly used in the food Industry
Active 
ingredients
Environmental 
surfaces
Food contact 
surfaces
Food tissues Restroom Handcare
Alcohols + + +
Oxidising 
compounds
+ +
Hypochlorite + + + - -
Quaternary 
ammonium 
compounds
+ + + + -
Phenolics - - - + -
Acid anionics + + - - -
Acified 
sodium 
chlorite
+ + + - -
Chlorine 
dioxide
+ + + - -
Triclosan - - - - +
Para-cholor-
meta-xylenol
- - - - +
Chlorhexidine - - - - +
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Triclosan 
Triclosan is commonly used in handcare products 
in the food industry. It works specifically on 
enoyl-acyl reductase, an enzyme which is essential 
for fatty acid synthesis. Modification, repression 
or deletion of the specific cellular target fabI	
(encoding enoyl-acyl reductase) results in reduced 
bacterial susceptibility to triclosan (McMurray, 
1998a; Gilbert and McBain, 2003; Randall, 2004) 
in food pathogens (E.	coli, Salmonella	spp. 
and Campylobacter spp.) and food spoilage (P.	
aeruginosa) organisms. Additionally, many of 
the Resistance-Nodulation-cell Division (RND) 
family of pumps associated with resistance to 
clinically-important antibiotics are able to expel 
triclosan. These include the AcrAB-TolC pump 
of E.	coli (McMurray, 1998b) and Salmonella	spp. 
(Piddock, 2000), the CmeABC and CmeDEF of C.	
jejuni (Pumbwe et	al., 2005), and several of the Mex 
pumps in P.	aeruginosa (Chuanchuen et	al., 2002). 
Quaternary ammonium compounds 
This group of biocide acts by physical disruption 
and partial solubilisation of the cell wall and 
membrane. For this reason, biocides are commonly 
used on environmental and food contact surfaces 
by the food industry. Resistance to QACs can be 
mediated through the action of nonspecific efflux 
pumps, along with other undesirable compounds 
from the interior of the bacterial cell. Coding for 
these pumps can be plasmid and chromosomally 
located, and both types have been described in 
both Gram-negative and Gram-positive bacteria 
(Gilbert and McBain, 2003). As stated earlier, the 
qacEð1 is mapped to the conserved segment (3’-CS) 
of a class 1 integron structure. The chromosomal 
efflux determinants of QAC resistance in Gram-
positive bacteria include the Major Facilitator 
(MF) family NorA multi-drug transporter (usually 
associated with fluoroquinolone resistance), the 
MF family MdeA, and the Multi-drug And Toxic 
Compound Extrusions (MATE) family MepA in S.	
aureus	(Huang et	al., 2004; Noguchi et	al., 2004; 
Kaatz, 2005). The main mechanisms of QAC 
resistance is chromosomally mediated, whilst in 
Gram-positive bacteria it is plasmid-borne, due 
to the Small Multi-drug Resistance (SMR) family 
transporters QacC/D and QacEΔ1, QacG, QacH 
and QacJ and the MF family QacA/B transporter 
(Poole, 2007). In contrast, the transporters capable 
of exporting QACs in Gram-negative bacteria are 
generally chromosomally encoded and include 
a number of MATE (PmpM in P.	aeruginosa), RND 
(AcrAB-TolC, AcrEF-TolC and YhiUV-TolC pumps of 
E.	coli), (Poole, 2005) and SMR family (EmrE in E.	
coli) (Yerushlmi et	al.1995) multi-drug transporters. 
The SMR transporters, QacE and QacEΔ1, QacF and 
QacG found in Gram-negative bacteria are plasmid-
encoded (Paulsen et	al., 1996; Poole, 2005).
Chlorhexidine
Chlorhexidine is used in hand-care products in 
the food industry. Bactericidal concentrations 
of chlorhexidine result in the denaturation 
of cytoplasmic proteins and coagulation of 
bacterial cell contents. The specific mechanism(s) 
associated with chlorhexidine resistance remain 
to be elucidated. However, chlorhexidine 
resistance is associated with cepA, which 
encodes a putative efflux mechanism in K.	
pneumoniae (Fang et	al., 2002). Benzalkonium 
chloride and triclosan adapted E.	coli, display 
a multi-drug-resistance phenotype including 
reduced susceptibility to chlorhexidine, 
consistent with increased expression of an RND 
multi-drug transporter (Braoudaki and Hilton, 
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remains to be conclusively established.
2005). Chlorhexidine has been shown to induce 
expression of the MexCD-OprJ efflux pump in 
P.	aeruginosa (Morita et	al., 2003) and QacA/B in 
Gram-positive bacteria reduces susceptibility to 
chlorhexidine (Morita et	al., 2003; Poole, 2005).
Evidence of links between antimicrobial and 
biocide resistance
The link between biocide exposure and the 
development of antibiotic resistance remains 
to be conclusively established. The theory of 
cross-resistance (to antibiotics or biocides) 
seems plausible; as resistance may be conferred 
by a shared mechanism (e.g. efflux pumps). 
Recent studies have shown that efflux pumps 
(sometimes with unusually broad specifcities) 
contribute to intrinsic resistance to agents, 
such as, antibiotics, dyes and detergents 
(Gilbert and McBain, 2003). Closer examination 
of the mechanisms involved and the potential 
role of efflux pumps might facilitate a clearer 
understanding of this relationship, and provide 
guidance on the appropriateness of such biocides, 
particularly in line with their expanding use.
Triclosan resistance
Many efflux pumps which confer resistance to 
triclosan also confer resistance to clinically-
significant antibiotics. Karatzas et	al. (2007) 
reported that in-vitro exposure to triclosan 
selected for Salmonella	spp. with reduced 
antibiotic susceptibility arising from the 
overexpression of the AcrAB-TolC efflux pump. 
Similar studies have reported the same findings 
for E.	coli (AcrAB-TolC) (Braoudaki, 2004a, 
Braoudaki, 2004b), C.	jejuni (CmeABC and 
CmeDEF) (Randall et	al., 2007), P.	aeruginosa	
(MexCD) (Chuanchuen et	al., 2001) and S.	
maltophilia (SmeDEF) (Sanchez et	al., 2005). 
While not all RND exporters may be significant 
determinants of triclosan resistance, their 
ability to export antibiotics and triclosan, 
highlights their potential contribution to the 
development of cross-resistance. The extent 
of this contribution requires epidemiological 
investigation (Poole, 2005).
No relationship between the use of triclosan 
and the development of antibiotic resistance 
has been reported in household studies (using 
products with/without triclosan) (Cole et	al., 
2003). Moreover, a study conducted over a 10-year 
period found no relationship between triclosan 
use and antibiotic resistance in MRSA and P.	
aeruginosa (Marshall et	al., 2003). Since triclosan 
is effective against a wide range of bacteria, 
cross-resistance currently is not considered a 
problem (Poole, 2005). 
Quaternary ammonium compounds  
and Chlorohexidine
Standard strains of E.	coli, Salmonella	spp. 
and S.	aureus	are highly sensitive to QACs and 
chlorohexidine and it is difficult to raise less 
susceptible subcultures (Russell, 2003). However, 
in	vitro exposure to sub-lethal levels of QAC 
has been shown to select for MDR (arising from 
overexpression of the AcrAB-Tolc efflux pump) in 
Salmonella	spp. and E.	coli (Braoudaki et	al. 2004a, 
2004b; Karatzas et	al. 2007). The relationship 
between chlorohexidine and RND transporters is 
not as well studied, as that of QAC’s (Poole, 2005). 
Triclosan and QAC adapted E.	coli isolates exhibit 
a MDR phenotype with reduced susceptibility to 
chlorohexidine (Braoudaki et	al., 2004a, 2004b). 
However, chlorohexidine adapted E.	coli isolates 
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are not reported to exhibit an MDR phenotype 
(Poole, 2005). Unlike the strains previously 
discussed,	P.	stutzeri	can be produced with 
markedly less susceptibility to chlorohexidine 
and QACs, in-vitro. These P.	seudomonas	stutzeri	
isolates demonstrate cross-resistance to some 
biocides and antibiotics (Tattawasart et	al., 1999; 
Tattawasart et	al., 2000a, 2000b). This cross-
resistance is attributed to an alteration in the 
cell’s outer membrane, resulting in a non-specific 
decrease in cell permeability (Russell, 2003).
Many epidemiological studies have found no 
relationship between biocide susceptibility and 
antibiotic resistance to biocides commonly used 
in hospital environments, including QACs and 
chlorohexidine (Alqurashi et	al., 1996; Suller et	al., 
1999; Bacquero et	al. 1991). However, a comparison 
of clinical and industrial isolates of P.	aeruginosa	
revealed that clinical isolates had higher levels 
of resistance to antibiotics. This was attributed 
to the selective pressure of antibiotic use in 
hospitals. However, the adaptive response of 
P.	aeruginosa to amikacin and tobramycin was 
accompanied by a low-level increase in tolerance 
to benzalkonium chloride (QAC) (Russell, 2003). 
Numerous studies have clearly demonstrated 
that selection for biocide resistance can 
result in cross-resistance to antibiotics in-
vitro (Moken et	al., 1997, Braoudaki and Hilton, 
2004a, 2004b). However, the true relationships 
between biocide use and antibiotic resistance, 
and the mechanisms involved, have as yet to be 
confirmed in epidemiological studies. 
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that would not otherwise occur; increased frequency of treatment failures; and 
increased severity of infection.
Introduction
Humans can be exposed to antimicrobial-
resistant bacteria through food derived 
from colonised animals, through increasing 
antimicrobial resistance in the environment and 
through food contamination during processing 
[see section 4]. Environmental contamination 
with resistant organisms, such as, surface waters, 
has also been reported, giving rise to concerns 
about direct exposure (Shea et	al., 2004). An FAO/
OIE/WHO meeting (Geneva in 2003) concluded 
that the emergence of antimicrobial-resistant 
organisms associated with non-human usage of 
antimicrobials posed adverse consequences to 
human health. More recently, new EU regulations 
banning the use of antibiotics as growth 
promoters in animals have been introduced 
in an attempt to reduce the emergence of 
antibiotic resistance in the food-chain. 
Human health effects of 
antimicrobial resistance
A CDC review reported on the extra human 
health consequences of antimicrobial resistance 
as opposed to the health effects caused by 
susceptible organisms, and identified three 
additional consequences: infections that would 
not otherwise have occurred if the organisms 
were not resistant; increased frequency of 
treatment failures; and increased severity of 
infection (Angulo et	al., 2004).
Infections that would not have otherwise 
occurred
When humans are taking antimicrobial medication, 
they are at increased risk of infection with resistant 
organisms, and in the US the number of additional 
infections as a result of resistant organisms in 
people taking antibiotics has been calculated 
(Barza and Travers, 2002). For instance, an 
additional 29,379 non-typhi salmonellae with 342 
hospitalisations and 12 deaths were estimated to 
occur, and the excess cases for C.	jejuni infections 
were calculated as 17,668 with 95 hospitalisations. 
Human health impact
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The increased severity of resistant infections has been demonstrated by greater 
hospitalisation rates.
Additional vulnerability to infection, for food 
animals receiving antimicrobials, may also result 
in an increase in infection and transmission from 
these animals (Angulo et	al., 2004). 
In the US, more than 400,000 extra days of 
diarrhoea per year, and 8,677 extra days in 
hospital, have been reported as attributable to 
infection with resistant organisms, compared 
with infection with susceptible organisms 
(Travers and Barza, 2002).
Increased frequency of treatment failures 
In a S.	Typhimurium DT104 outbreak, two deaths 
in patients treated with fluoroquinolones 
were considered flouorquinolone-resistance-
related by the coroner (Angulo et	al., 2004). In 
the same review, it was reported that patients 
taking fluoroquinolones, who have resistant 
Campylobacter infection, have been found to have 
several additional days of diarrhoea. 
A potential lack of therapeutic options is a real 
concern, for example, the drug of choice in the 
treatment of children with invasive Salmonella	
spp. disease, ceftriaxone, was not an option 
in a child with ceftriaxone-resistant strain 
of Salmonella	spp. associated with the same 
organism in a local outbreak of salmonellosis in 
cattle (Fey et	al., 2000). 
Increased severity of infection
The increased severity of resistant infections has 
been demonstrated by greater hospitalisation 
rates, and greater case fatality rates (Angulo et	al., 
2004). Increased risk of bloodstream infections 
has also been seen, as well as death within 90 
days (Angulo et	al., 2004).
Mortality associated with infections with 
resistant organisms
Helms et	al. (2002) found an increased risk of 
death over two years in those infected with S.	
Typhimurium –59 out of a total of 2047 patients 
died as a result of S.	Typhimurium. Even for 
susceptible Salmonella	spp. the risk of death 
was 2.3 times more than for the general Danish 
population (adjusted for age and co-morbidity). 
With multi-resistance including quinolone 
resistance, the risk of death increased by a factor 
of 10.3 (95 per cent CI 2.8-37.8) (Helms et	al., 2002). 
Changes increasing the vulnerability of  
host populations
As survival times following cancer treatment, 
transplantation and other chronic diseases, 
such as diabetes mellitus and autoimmune 
diseases increases so does the pool of immuno-
suppressed patients alive in the community. 
Improved life expectancy and the greater survival 
of premature infants also increase the population 
of those most vulnerable to any infections, and 
particularly resistant infections.
Economic and other costs to health services
In the US, varying proportions of antimicrobial 
use for veterinary purposes have been reported: 
from 40 per cent of all antimicrobials used, with 
only about a quarter of this used for therapeutic 
reasons to 78 per cent of all antimicrobials use 
being used in food animals for non-therapeutic 
reasons (Shea et	al., 2004). This indicates that 
antimicrobial agent use in food animals is a 
sizable problem and its side effects may present a 
major challenge to veterinary public health.
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Human healthcare is costly and as a result, 
resources must be managed in the most cost-
effective manner. Efforts to control antimicrobial 
resistance through prudent use of antibiotics 
and through ‘search and destroy’ policies are 
threatened by imprudent use in human and 
animal healthcare. In The Netherlands, for 
instance, MRSA prevalence in farm families is 
much higher than in the general population, 
where human healthcare policies have been 
successful and this new source of antimicrobial 
resistance is outside the direct influence and 
control of human health services. 
Options are reduced in the treatment of AMR 
resistant infections requiring the use of more 
expensive and often toxic drugs. So even if an 
effective alternative treatment is available, this 
potentially avoidable cost could be prevented. 
Infected individuals are a source of infection 
for others, so prolonged illness, as occurs with 
many resistant organisms, increases the cost 
of isolation and other control measures. There 
is also an increased risk of cross-infection and 
outbreaks, which apart from the significant human 
costs would escalate the economic impacts of 
healthcare. This is very important as hospitals are 
populated by particularly vulnerable people. Other 
complicating factors need to be considered, for 
example, increased hospital stays lead to increased 
bed occupancy and possible overcrowding, which 
increases the risk of cross-infection. 
Increased morbidity and mortality, again apart 
from the human cost to patients and their families, 
are potential sources of litigation, which even if 
negligence is not proven, are costly to defend. 
Opportunity costs – increased costs for 
healthcare, longer hospital stays, more intensive 
therapy, more expensive treatments, more 
complications, more after-care divert the use 
of scarce resources from other important 
health needs, thereby using resources for other 
healthcare provision, such as, cancer treatments 
which cannot always be afforded. 
Human antimicrobial resistance 
surveillance:
There are two basic elements to human AMR 
data, antimicrobial consumption data and data 
on pathogen testing. There are well-recognised 
limitations to the data sets both in terms of 
accuracy and completeness. Some of these 
include: lack of antimicrobial prescription, sale 
and consumption data; only a limited number 
of clinically important pathogens are tested for 
resistance; sampling strategies and laboratory 
methods are not standardised and not all isolates 
are tested for all antimicrobials. A detailed review 
of the available data is outside the scope of 
this document. However, relevant data can be 
sourced from the following websites: ESAC (EU 
Surveillance of Antibiotic Consumption), ECDC, 
EARSS, CDSCNI and HPSC.
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Both SARI and AMRAP have recommended the development of guidance in 
relation to the appropriate use of antimicrobials (in humans), as well as monitoring 
the supply and use of antimicrobials in hospitals and the community.
Solutions
8
Prudent use of antimicrobial agents
On the island of Ireland there are two AMR 
strategies, namely SARI (Strategy for the control 
of Antimicrobial Resistance) in ROI and AMRAP 
(Antimicrobial resistance Action plan) in NI. 
Both SARI and AMRAP have recommended the 
development of guidance in relation to the 
appropriate use of antimicrobials (in humans), 
as well as monitoring the supply and use of 
antimicrobials in hospitals and the community 
(NDSC, 2001). Education in relation to the human 
health use of antimicrobials and hygiene were 
also recommended and some materials have  
been developed to assist with this. There have 
also been two joint conferences aimed at  
relevant professionals.
However, success in the implementation of 
prudent prescribing of antimicrobials in human 
healthcare is complex. Research has been 
undertaken on prescribing practices focusing 
on financial cost (Parrino, 1989), knowledge and 
attitudes of physicians (Poses and Anthony, 1991; 
Ehedahl et	al., 1995) and the attitudes of patients 
or parents towards the inappropriate use of 
antimicrobials (Palmer and Bauchner, 1997). 
The most recent evidence indicates that even 
when the need for rational prescribing is 
accepted, there are ongoing challenges to achieve 
best practice.
In veterinary practice, international guidelines on 
the responsible and prudent use of antimicrobials 
have been developed by the Office International 
des Epizooties (Anthony et	al., 2001). 
According to a review by Collignon (Collignon 
2004), there is an absence of evidence of any 
significant benefit to agriculture from the use of 
antimicrobials as growth promoters. Prohibiting 
the use of antimicrobials as growth promoters 
has a major effect on reducing the pool of 
resistant organisms with minimal effect on 
productivity (Wegener, 2003). Alternative animal 
health care strategies have been proposed, 
for example, because of resistance clustering 
within herds, prevention strategies at herd level 
interventions (Rosengren et	al., 2008). 
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The European Food Safety Authority (EFSA) has 
reported that:
“in terms of impact, controls operated at the 
pre-harvest phase, for example, those aimed at 
the control and limitation of antimicrobial usage 
are potentially the most effective and as such are 
capable of playing a major role in reducing the 
occurrence of antimicrobial resistant bacteria in 
food as presented for sale” (Scientific Opinion of 
the Panel on Biological Hazards on a request from 
the EFSA on foodborne antimicrobial resistance as 
a biological hazard, 2008).
Need for on-going surveillance
Even with strict adherence to guidelines, as long 
as antimicrobials are used at all, resistance will 
remain a threat and, therefore, there is a need for 
on-going human and animal surveillance, both 
to monitor the outcomes of co-ordinated control 
efforts and for the early identification of new 
resistance threats.
EFSA has recommended:
“the development and application of new 
approaches to the recognition and control of food 
as a vehicle for antimicrobial resistant bacteria 
and related genes based on epidemiological and 
source attribution studies directed towards fresh 
crop-based foods, raw poultry meat, raw pigmeat 
and raw beef” (Scientific Opinion of the Panel on 
Biological Hazards on a request from the EFSA on 
foodborne antimicrobial resistance as a biological 
hazard, 2008).
The existing human AMR surveillance systems are 
briefly described in section 8 of this report.
In animal health surveillance there is a less well 
developed standardised surveillance system across 
Europe. Surveys have been carried out in local 
areas. In the ROI for example, monitoring of in-line 
milk filters found Salmonella	infection in six per 
cent of herds, and all strains found were resistant 
to at least one antibiotic (Murphy et	al., 2008).
The Community Summary Report on Trends 
and Sources of Zoonoses Zoonotic Agents and 
Antimicrobial Resistance in the European Union 
was first published by EFSA in 2006. 
Surveys have also been carried out internationally, 
showing carriage of antimicrobial resistance 
across species and across countries (Bywater et	
al., 2004).
A model for continuous surveillance for 
antimicrobial resistance among isolates from 
food animals exists since 1995 in Denmark 
(Aarestrup, 2004). The benefits of the Danish 
surveillance system are felt internationally as 
this source of surveillance data has informed 
international scientific knowledge in recent years. 
However, Aarestrup recommends: “an organised 
monitoring of antimicrobial resistance carried out 
by an international network” (Aarestrup, 2004). 
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Structured surveillance systems which integrate animal, human and food chain 
surveillance across jurisdictions, are necessary to ensure effective public health 
planning and intervention across the island of Ireland.
Recommendations
9
The recommendations below are grouped in to 
two categories:- surveillance and research issues. 
The surveillance issues focus on the crucial inter-
locking role of safefood between veterinary and 
clinical medicine, to achieve an overall quality of 
data for the people on the island of Ireland. The 
research issues reflect specific research areas 
in support of the particular role of safefood in 
consumer protection.
Surveillance issues:
• Current levels and intensities of AMR 
surveillance vary widely between the animal 
population, the food chain, and the human 
population. Much of such work is episodic, 
with little or no ongoing surveillance or wider 
harmonization across the island. Structured 
surveillance systems which integrate the 
above aspects, across jurisdictions, are 
necessary to ensure effective public health 
planning and intervention across the island  
of Ireland.
• An integrated AMR monitoring programme, 
with a clear emphasis on those areas that are 
currently underdeveloped, i.e. food-borne 
AMR, should be developed on the island of 
Ireland (e.g. DANMAP model). Food safety in 
relation to AMR should be informed by risk 
assessment of the impact of environmental 
exposure to antimicrobial agents.
• Integrated monitoring of antimicrobial 
prescribing, dispensing and consumption 
patterns in human and animal populations 
on the island of Ireland is required. These 
monitoring systems should be linked and 
ongoing.
• Programmes promoting the prudent use of 
antimicrobial agents in animal and human 
medicine on the island of Ireland should 
link with all Food Safety agencies. Current 
programmes promoting the prudent use of 
antimicrobial agents (in both jurisdictions) 
should be supplemented and extended, to 
ensure adequate coverage in relation to the 
food production, processing, and retail chain.
• A Forum on Food Safety and AMR should be 
established. Relevant stakeholders should 
include policy makers, food industry, food 
scientists, environmental protection agencies 
and medical and veterinary professionals (a 
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‘One Medicine’ approach). The forum should 
be a collaborative network and have the 
capacity to hold conferences, issue reports, 
and act to ensure improved public safety in 
relation to the risks posed by AMR bacteria in 
the human food chain.
Research issues:
• Research into the potential dangers and 
impacts of AMR on current and alternative 
food technologies should be conducted in 
association with food industry partners. 
Initially, this work should focus on 
technologies such as minimal processing and 
probiotic supplementation of food products.
• Food attribution studies should be carried 
out to estimate the fraction of food animal 
associated AMR infections on the island of 
Ireland with a view to supporting ongoing 
identification and prioritisation of hazards 
posed by (and interventions for the reduction 
of) such AMR. These should be stratified 
by populations and regions on the island 
of Ireland, as the attributable fractions in 
different communities, e.g.: urban versus 
rural, are unlikely to be the same.
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Appendix
Table 1 Classes of antimicrobials, examples of substances used in human and veterinary medicine 
and examples of resistance genes. (Modified from EFSA, 2007 – Opinion on foodborne antimicrobial 
resistance as a biological hazard).
Note:	There	is	generally	complete	or	partial	cross	resistance	within	each	class	or	subclass	unless	otherwise	
indicated.
See Table 1 over leaf.
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Class
Exam
ples of substances used in:
H
um
an m
edicine
Veterinary m
edicine; 
food production 
anim
als in EU
Resistance genes
Com
m
ents
A
m
inoglycosides
am
ikacin, gentam
icin, 
netilm
icin, tobram
ycin
apram
ycin, 
gentam
icin, 
streptom
ycin
aac,	aad	(ant),	aph,	
arm
A,	rpsL	(strA)	rpsD
,	
rpsE,	strB
N
o general cross-
resistance w
ithin 
class, but som
e 
types of resistance 
w
ill involve cross-
resistance betw
een 
som
e am
inoglycosides
kanam
ycin, 
spectinom
ycin
neom
ycin, 
spectinom
ycin
A
m
phenicols
chloram
phenicol, 
tiam
phenicol
chloram
phenicol, 
florfenicol, 
tiam
phenicol
cat,	cfr,	cm
l,	flo
crf confers cross-
resistance to 
am
phenicols, 
lincosam
indes, 
pleurom
utilins, 
streptogram
ins, 
linezolid
Beta-lactam
 
antibiotics
Penicillins
Benzyl-penicillin, 
am
picillin, am
oxicillin 
(w
ith clavulanic acid)
benzyl-penicillin, 
am
picillin, am
oxicillin 
(w
ith clavulanic acid)
blaZ	(bla-PC),	bla-TEM
.	
bla-SH
V
Cross resistance 
w
ithin sub-classes but 
also, depending on 
m
echanism
, betw
een 
subclasses
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Pe
ni
ci
lli
ns
	–
	
an
ti
st
ap
hy
lo
co
cc
al
cl
ox
ac
ill
in
, 
di
xc
lo
xa
ci
lli
n 
(m
et
hi
ci
lli
n)
cl
ox
ac
ill
in
, 
di
cl
ox
ac
ill
in
 
bl
a-
O
XA
,	m
ec
A	
Ce
ph
al
os
po
rin
s,
	fi
rs
t	
ge
ne
ra
ti
on
ce
ph
al
ex
in
, c
ef
az
ol
in
, 
ce
ph
al
ot
in
ce
fa
zo
lin
, c
ep
ha
le
xi
n
bl
a-
TE
M
.	b
la
-S
H
V,
	b
la
-
CT
X,
	b
la
-C
M
Y,
	s
om
e	
bl
a-
O
XA
Ce
ph
al
os
po
rin
s,
	s
ec
on
d	
ge
ne
ra
ti
on
ce
fu
ro
xi
m
e,
 lo
ra
ca
rb
ef
-
Ce
ph
al
os
po
rin
s,
	t
hi
rd
	
ge
ne
ra
ti
on
ce
ft
az
id
im
e,
 
ce
ft
ri
ax
on
e
Ce
ft
io
fu
r
Ce
ph
al
os
po
rin
s,
	fo
ur
th
	
ge
ne
ra
ti
on
ce
fe
pi
m
e,
 c
ef
pi
ro
m
e
ce
fe
pi
m
e,
 c
ef
qu
in
om
e
Ce
ph
am
yc
in
s
ce
fo
xi
ti
n
bl
a-
CM
Y,
	b
la
-A
AC
Ca
rb
ap
en
em
s
er
ta
pe
ne
m
, i
m
ip
en
em
, 
m
er
op
en
em
-
bl
a-
IM
P,
	b
la
-V
IM
,	s
om
e	
bl
a-
O
XA
Cy
cl
ic
 p
ol
yp
ep
ti
de
s
Ba
ci
tr
ac
in
(b
ac
it
ra
ci
n)
bc
rA
BD
Fo
rm
er
ly
 u
se
d 
as
 fe
ed
 
ad
di
ti
ve
 in
 E
U
G
ly
co
pe
pt
id
es
te
ic
op
la
ni
n,
 
va
nc
om
yc
in
- 
(a
vo
pa
rc
in
)
va
n	
(A
-E
)
Fo
rm
er
ly
 a
vo
pa
rc
in
 
w
as
 u
se
d 
as
 fe
ed
 
ad
di
ti
ve
 in
 E
U
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Ionophores
-
m
onensin, 
salinom
ycin
U
sed as coccidiostats
Lincosam
ides
clindam
ycin, 
lincom
ycin
clindam
ycin, 
lincom
ycin
cfr,	erm
Cross-resistance also 
to m
acrolides and 
streptogram
inB for 
certain resistance 
genotypes
Lipopeptides
daptom
ycin
-
M
acrolides &
 
ketolides
erythrom
ycin, 
spiram
ycin, 
azithrom
ycin, 
clarithrom
ycin
spiram
ycin, tylosin, 
tulathrom
ycin
erm
,	ere,	m
ef,	m
sr
Cross-resistance also 
to lincosam
ides and 
streptogram
inB for 
certain resistance 
genotypes
N
itrofurantoins
furazolidone, 
nitrofurantoin
-
U
sed form
erly as 
veterinary m
edicine
N
itroim
idazoles
m
etronidazole, 
tinidazole
-
D
im
etridazole and 
ronidazole used 
form
erly as veterinary 
m
edicine
O
rthosom
ycins
-
Avilam
ycin
em
tA
U
sed form
erly as feed 
additive
O
xazolidones
linezolid
-
cfr
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Pl
eu
ro
m
ut
ili
ns
-
ti
am
ul
in
, v
al
ne
m
ul
in
cf
r
Po
ly
m
ix
in
s
co
lis
ti
n,
 p
ol
ym
ix
in
 B
 
co
lis
ti
n,
 p
ol
ym
ix
in
 B
Q
ui
no
lo
ne
s
na
lid
ix
ic
 a
ci
d,
 
ci
pr
ofl
ox
ac
in
 
no
rfl
ox
ac
in
, 
m
ox
ifl
ox
ci
n
da
no
fl
ox
ac
in
, 
en
ro
fl
ox
ac
in
, 
aa
c(
6’
)-
Ib
-c
r,	
gy
rA
.	
pa
rC
,	q
ep
A,
	q
nr
,	
In
co
m
pl
et
e 
cr
os
s-
re
si
st
an
ce
 
Q
ui
no
xa
lin
es
-
ca
rb
ad
ox
, o
la
qu
in
do
x
oq
xA
B
O
la
qu
in
do
x 
us
ed
 
fo
rm
er
ly
 a
s 
fe
ed
 
ad
di
ti
ve
 in
 t
he
 E
U
St
re
pt
og
ra
m
in
s
pr
is
ti
na
m
yc
in
, 
qu
in
pr
is
ti
n/
da
lfo
pr
is
ti
n
- 
(v
ir
gi
ni
am
yc
in
)
cf
r,	
er
m
,	v
ga
	,	
vg
b
Fo
rm
er
ly
 v
ir
gi
ni
am
yc
in
 
w
as
 u
se
d 
as
 fe
ed
 
ad
di
ti
ve
 in
 E
U
Cr
os
s-
re
si
st
an
ce
 
be
tw
ee
n 
st
re
pt
og
ra
m
in
B,
 
lin
co
sa
m
id
es
 a
nd
 
m
ac
ro
lid
es
 fo
r 
ce
rt
ai
n 
re
si
st
an
ce
 g
en
ot
yp
es
Su
lp
ho
na
m
id
es
 &
 
tr
im
et
ho
pr
im
su
lf
ad
ia
zi
ne
, 
su
lf
am
et
ho
xa
zo
le
, 
tr
im
et
ho
pr
im
su
lf
ad
ia
zi
ne
, 
su
lf
ad
ox
in
e,
 
su
lf
am
et
ho
xa
zo
le
, 
tr
im
et
ho
pr
im
df
r,	
su
l
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Tetracyclines
chlortetracycline, 
doxycycline, 
oxytetracycline
chlortetracycline, 
doxycycline, 
oxytetracycline
tet	
M
iscellaneous
-
fl
avophospholipol 
(bam
berm
ycin)
U
sed form
erly as feed 
additive
fosfom
ycin
-
fosAB
fusidic acid
fusidic acid
fusB
M
upirocin
-
m
upA
U
sed in hum
an 
m
edicine 
topically for M
RSA
 
decontam
ination
Rifam
picin
(rifam
picin)
rpoB
U
se in vet. m
ed 
lim
ited to foals
O
xazolidones
linezolid
-
cfr
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